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1. Introduction 
The cardiac surgery continues having a fundamental roll in the therapeutic arsenal of many 
heart deseases in spite of the spectacular advances that determined drugs or different forms 
of interventionist cardiology have experimented during the past few years. The present 
impact of the heart surgery is due to the constant increase of the cardiovascular risk factors, 
related to the increase in the life expectancy in last the three decades, the clinical approach of 
the ischemic cardiopathy towards the repair has taken to the creation and development of 
techniques and methods at the moment used in the miocardic revascularization surgery; the 
roll of the coronary surgery initiated by Sabiston in 1962 and popularized by Favaloro in 
1967 has had an exponential development with the purpose of to exclude the ill part from 
the artery by placing a bypass to improve the perfusion of the ischemic area. Nevertheless 
the other side of the balance is the pharmacological treatment whose objective is to look for 
the balance between the supply and demands in the ischemic scope at the expense of a 
smaller consumption of oxygen (VO2), diminution of the inflammatory local metabolism, 
control of trombotics phenomena, etc. Now on the basis of the knowledge and acquired 
experience we establish a margin of durability of 90% to 10years in grafts of internal 
mammary  (AMI) and 50-60% of venous grafts (HV), depending on the vascularized area 
and the type of vein, in relation to the arterial grafts the average life is of 90% to 5 years with 
sufficient information of early stenosis problems. Most of the post-operated patients recover 
in a fast and complete form, which depends on the quality of the performed surgery and an 
opportune and suitable handling as all the symptoms of the organism recover of the effects 
of: anesthesia, cardiopulmonary derivation (CEC) and surgical stress. Nevertheless some 
patients who present combinations of indicators of preoperative risk like: age outpost, 
antecedents of miocardic revascularization, recent and acute miocardic heart attack (IAM), 
ejection fraction (EF) low or diabetes, have a much greater surgical risk to the one of the 
habitual patient. At the moment there are certain characteristics that have determined a fast 
recovery as they are the early extubation, to avoid major sedation, the disconnection of the 
support devices and the suspension of drugs as rapidly as possible. A fast treatment before 
a: Low cardiac cost, alteration of the pulmonary function, hemorrhages, coagulopathy and 
fever is essential to be able to obtain a fast recovery of the patients; at the moment the 
surgical indications of the miocardiac revascularization (RVM) have been based in relation 
to the number and degree of affectation of the coronary arteries, decreased ventricular 
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Special Topics in Cardiac Surgery 2 
function and more and more by the increase of percutaneous interventions there are patients 
with greater risk and worse diagnosis which has modified the results in the last years, as 
well as a reduction in the number of surgeries per year. Mortality in Europe and the United 
States is lower than 2,5% with a survival that oscillates respectively between 97-80% of 1 
to15 years. Its reduction increased as of the eighth year, is in relation to the average life of 
the grafts, its occlusion, progression of the disease and development of its comorbidities. 1,2,3. 
2. Preoperative surgical risk  
From the antiquity, man has tried to anticipate or predict the facts to come, that is to say the 
prediction of the results in cardiovascular surgery has been and continues being a goal. The 
stratification of the patients in different risk levels, previous to the accomplishment of a 
cardiovascular surgery has diverse intentions, among them the clinical decision making 
with respect to the accomplishment or not of the surgical procedure or the derivation of the 
patient for another type of treatment. It is necessary to establish preoperative conducts that 
can reduce the risk to cost-effectiveness, to establish the stratification of the risk sometimes 
is difficult, being implicit some factors of individual risk that can be interpreted of different 
way and has like objectives:  
1. Identification of patients of high risk with critical allocation, to adapt the perioperatory 
problems.  
2. To diminish the morbidity and mortality, establishing strategies of preoperative, 
intraoperating and post-operative treatment.  
3. It is indispensable to know the heart disease suitably. (Physiopathology, diagnosis, 
treatment, and perioperatory complications).  
4. A suitable evaluation and treatment of the cardiopathy surgical patient, requires a team 
work and communication between: patient-surgeon, cardiologist and intensivist.  
5. Several factors are known that modify the individual risk as they are the age, the sort, 
previous the cardiovascular function, the renal diseases and you will tilt, respiratory 
function and other related factors. 
John and collaborators established 7 fundamental criteria like and 13 important criteria 
which are an influence in the morbi-mortality of the post operated patient. (CHART 1) 
Age 
Every time it is more frequent than patients with age greater to 60 years, are admitted. The 
cardiovascular risk is increased by above of 65 years by the presence of his comorbidities, 
age outpost with cardiac symptoms and a key point is the selection of this type of patients, 
since with this secondary mortality to the surgery is determined. In these patients it is 
frequent the existence of important complications as they are the low cardiac cost, acute 
myocardial infarct of the perioperatory, surgical re-intervention by bleeding, acute renal 
insufficiency, pneumonia, prolonged ventilation, all these increase to the percentage of 
complications and mortality.  
Gender 
Many studies exist that have determined that the woman has a greater risk of mortality after 
the coronary revascularization; because they have minor corporal surface and the size of the 
coronary glasses is smaller. As far as the sort it does not seem to be predictive of mortality in 
valvular procedures, mitral and aortic.  
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Predictors of post-CABG mortality 
Age  
Sex  
Urgency of operation  
Prior heart surgery  
LVEF  
Percent stenosis of LM coronary artery  
Number of major coronary arteries with 
>70% stenosis 
Height  
Weight  
PCI during current admission  
Date of most recent MI  
History of angina  
Ventricular arrhythmia 
CHF 
Mitral regurgitation 
DM 
CVD 
 PVD 
COPD 
Creatinine level 
Chart 1. 
Cardiovascular state 
Is the most important aspect of perioperative mortality, the important factors are: severe 
valvular disease, reoperation, left ventricular function, infarct to the myocardium previous, 
cardiac insufficiency, emergency surgery and upheavals of the rate.  
Respiratory function 
The pulmonary disease chronicle is a risk factor to prolong the mechanical ventilation, to 
have a more difficult weaning, and associated to the pulmonary arterial hypertension, its 
extubation requires major care.  
Mortality 
The explanation of the diminution in mortality has been the present methods of myocardic 
protection with retrograde cardioplegia, hypothermia since the ischemia diminishes 
triphosphate of adenosine (ATP), altered sanguineous flow, calcium overload, reduction of 
intracellular calcium sensitivity, sarcoplasmatic dysfunction and the presence of free oxygen 
radicals. The morbidity and mortality fall significantly in spite of being increased the risk 
factors, the tendency of the secondary complications of comorbid sufferings have increased 
until in 30-40%.  
The preoperative cardiovascular evaluation provides recommendations for stratification 
with risk and handling of proposals by the American College of Physicians: Medical history, 
clinical exploration, ECG, X-ray of thorax, laboratories, tests ECG to the exercise, 
ambulatory monitoring (Holter), ventriculography to radio nuclear, heart ultrasound, 
coronary angiography, thallium scintiscanning. 4.5.6.7.8.9 (CHART 2)  
In resistance to indices of multi-factor risk, the functional classification New York Heart 
Association (NYHA) and the American Society of Anesthesiology (HANDLE) are used of 
routine by the anesthesiologist. Nevertheless, these classifications do not designate a 
predicting result after the surgery reason why its predictive ability in operating room is 
limited. 
ASA 
Healthy patient, with a process located without systemic affection.  
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PREOPERATIVE EVALUATION OF CARDIAC SURGERY 
History 
1. History of bleeding: Use of antiplatelet and anticoagulant medication. 
2. Smoking (COPD, bronchospasm). 
3. Alcoholism (cirrhosis) 
4. Diabetes (reactions to protamine, prior infection) 
5. Neurological symptoms. 
6. Venous insufficiency. 
7. Distal vascular reconstruction. 
8. Urologic symptoms. 
9. Gastric ulcer or gastrointestinal bleeding. 
10. Infections (Urol) 
11. Allergies 
Physical Examination. 
1. Skin infection / rash. 
2. Dental Caries (dental) 
3. Vascular examination (carotid, abdominal aneurysm and peripheral pulses) 
4. Heart / Lung (congestive heart failure, new murmur). 
5. Varicose veins. 
Laboratories 
1. Hematologic: PT, PTT, platelets, Hb, Time Ivy. 
2. Chemistry: Electrolytes, BUN, QS, PFHS. 
3. Urinalysis. 
4. Chest X-ray AP and lateral. 
5. Electrocradiogram. 
Chart 2. 
Patient with slight systemic disease.  
Patient with serious, but non incapacitated systemic disease.  
Patient with serious and incapacitated systemic disease, that constitutes a constant threat for 
the life.  
Dying patient, whose life expectancy does not exceed the 24 hours, is realized or not it to his 
surgery.  
NYHA  
Patient with heart disease, without limitations of physical activity.  
Patient with disease, with slight limitation ofordinary physical activity, fatigue, palpitations, 
designs or angina pain.  
Patient with heart disease, with noticeable limitation of physical activity, less than the 
ordinary physical activity, cause tires, palpitations design or pain angina.  
Patient with heart disease, incapacity to walk and physical activity, symptoms of cardiac 
insufficiency, angina.  
There are over 100 studies of perioperatory risk-prognosis stratification that have tried to 
identify adverse predictive factors, the greater limitation of these studies is that they were 
realized in a single institution, small groups, or the cardiac experience of the 
anesthesiologistwas the one taken into account. Between the preoperative risk-prognosis 
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classifying stratification, transoperatory and post-operative factor risks are the following 
scales: Parsonnet, Tumman, Higgins, Tu, Hannan, Connor, Cleveland Clinic, EuroSCORE, 
Ontario Provincial Risk (OPR) among others, which vary in predicting correlation of risk of 
morbidity and mortality in relation to distribution of patients by risk, the average one 
hoped, and the averageobservada.10, 11.12.13 (Chart 3) 
3. Stratification of risk using data base 
The basic information of data is used to improve the clinical practice producing reports with 
validity and application, evaluating the results, optimizing and improving the cares of the 
patient, the high mortality is identified in a small and specific sub-group classified like of 
high risk. The obtained results are used to change institutional programs diminishing 
mortality in patients of high risk like of smaller risk, mainly in patient put under coronary 
revascularization diminishing the mortality from 4,5% to 1,5%.  
The European for System Cardiac Operative Risk Evaluation (EuroSCORE) is a predicting 
logistic model of hospitable mortality in patients submissive cardiac intervention, starting 
off of 18 variables of risk and with a coefficient beta associated to each of them, it provides 
the probability of dying of each individual, this model was created and validated initially in 
across-sectional study of 19,030 European patients in 1999, and it has become, since then, in 
the used model more in the world in this type of patients. Most of the authors agree in 
raising that the Euroscore is a system simple additive that it provides to facultative a tool of 
easy handling to consider the death risk. A variant of the much more simple logistic model, 
denominated Euroscore additive, that awards a weight determined to each factor of risk that 
presents the patient, the sum of these weights exists provides the approximated probability 
to die. 
The interesting exercise to compare logistic Euroscore with additive already has been 
realized, but in fact it contributes certain confusion, and the conclusions that are obtained 
are understood easily observing. 
The preoperative surgical risk models are made on the basis of cardiac surgery using 
cardiopulmonary bypass (CPB). However, it can be applied to off-pump cardiac surgery, as 
evidenced by Vazquez Roque, in a study in 208 patients undergoing bypass surgery without 
cardiopulmonary bypass and found that the mean EuroSCORE was significantly higher in 
patients who died. When comparing patients with and without major complications can see 
that the mean EuroSCORE was also significantly higher in patients with major 
complications. 
Without fatal perioperative morbidity results in an increase of stay in postoperative care 
unit and overall hospital stay, this increases resource consumption and costs per patient. 
The EuroSCORE proved to have a discriminating power and acceptable calibration in 
predicting these events, we can say that Euroscore, despite being designed a risk score based 
on patients who underwent cardiac surgery using CPB may be used to predict the risk of 
death and major complications in patients who are going to be revascularized without the 
use of cardiopulmonary bypass. This is a novel technique that still suffers from risk scores 
based on the preoperative characteristics of their own patients. The study uses databases 
Euroscore retrospective studies, to provide predictive models of morbidity, mortality and 
prolonged stay in the postoperative intensive care unit, which can be used to improve the 
quality of postoperative care in different institutions is a tool to categorize patients for 
cardiac surgery in several subgroups.  
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Risk factors Punctuation 
Female sex 1 
Morbid obesity 3 
Hypertension (p. s.> 140 mmHg) 3 
EJECTION FRACTION  
Good> 50% 0 
Moderate 30-49% 2 
Poor <30% 4 
age years  
70-74  7 
75-79 12 
>80  20 
Reoperation  
Primary 5 
Secundary  10 
Preoperative BIAC 2 
Left Ventricular Aneurysm 5 
Emergency surgery and angioplasty 10 
Dialysis 10 
Catastrophic States 10-50 
Mitral valve surgery 5 
PAP > 60mmHg 8 
Aórtic 5 
Gradient > 120 mmHg  7 
Revascularization + Valve Surgery 2 
Chart 3. 
Due to differences in adult cardiac surgery in the countries of Europe the EuroSCORE is 
responsible for assessing the quality of surgical care, the analysis is performed for each 
individual to individual and predicting mortality among the countries of the study is were: 
Germany, England, Spain, Finland, France and Italy. The EuroSCORE model was 
satisfactory in all countries with a p <0.05, despite epidemiological differences between 
European countries the discriminative power of EuroSCORE was good in Spain and in other 
countries excellent. 14, 15,16,17, 18,19,20. 
4. Cardiac risk evaluation of anesthetic (CARE) 
The scale used most recently is called Cardiac Anesthesia Risk Evaluation Score (CARE), 
prospective studies in cardiac surgery demonstrated a significant number of prognostic 
information was obtained from only a few clinical variables or clinical trial, were validated 
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and compared with 3.548 patients with Parsonet, Tuman, and Tu, the CARE is a simple risk 
classification predicts morbidity and mortality on a scale which means ordinary CARE1 low 
risk, high risk means CARE5 and Care 2-4 as intermediate risk, based on clinical trial 
recognized three variables: 21.22  
Scale of anesthetic Cardiac Risk Assessment (CARE). 
 Heart disease stable without other medical problems, surgery scheduled for a low 
surgical risk. 
 stable heart disease with one or more controlled medical problems, set to a low-risk 
surgery. 
 uncontrolled medical problem, or patient scheduled for surgery high risk. 
 uncontrolled medical problem, scheduled for surgery high risk. 
 advanced or chronic heart disease, scheduled for cardiac surgery that delayed it can 
complicate or improve their lives. 
Cardiopulmonary bypass (CBP) 
On-pump bypass also known as cardiopulmonary bypass is a method used in coronary 
bypass surgery, this device has been used in cardiac surgery since 1960, due to the high 
incidence of perioperative mortality due to low spending, it is increasingly used in the last 
decade, increasing its survival up to 60%. Cardiac surgery and cardiopulmonary bypass 
activate the inflammatory response, characterized by cardiovascular and pulmonary 
disorders, this inflammatory response that occurs during cardiac surgery is presented by 
three processes: 
 Contact of blood with the cardiopulmonary bypass machine. 
 Development of ischemia and reperfusion injury. 
 Release of endotoxins. 
The extent and duration of the inflammatory response depend on many factors including 
the composition of the solution pump, the presence of pulsatile perfusion, pharmacological 
agents used to reduce the response, the use of mechanical filtration, the type of 
extracorporeal circuit and temperature during cardiopulmonary bypass. During CPB flow 
decreased splenic occurs, which induces the crossing of endotoxins by the lumen, activating 
the inflammatory response, endotoxins are potent initiators of the inflammatory cascade, 
which in turn causes production of cytokines and complement activation.  
A frequent complication of systemic inflammatory response is the evolution to multiple 
organ failure (MOF) including respiratory failure, shock and renal failure, development of 
FOM is the most important determinant for the postoperative increases those patients who 
have risk factors such as prolonged mechanical ventilation (intubation ≥ 48 hours), increased 
volumes of lower urinary nitrogenous and persistence of vasopressors, resulting in an 
increase in mortality to 41%. The inflammatory response and also condition FOM 
phenomena of hemolysis, thrombocytopenia and leukopenia, in the first 24 hours of the end 
of cardiopulmonary bypass can be seen that the total count of leukocytes undergoes an 
increase with significant changes in the differential count, the leukocytosis persisted in 72 
hours, in the differential count reports a significant increase in neutrophils and monocytes 
and decreased lymphocyte counts during the first days. Postoperative fever in the second 
and third day in patients undergoing cardiac surgery is accompanied by an increase in 
neutrophils, two times the initial value during cardiopulmonary bypass activation of 
neutrophils is manifested by leukocyte sequestration in the pulmonary circulation at the 
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time of reperfusion of the vascular bed can lead to endothelial and parenchymal injury, in 
immunocompromised patients and prolonged intubation favors the development of 
infections. Neutrophils represent the most significant source of oxygen free radicals, which 
is associated with myocardial dysfunction and pulmonar.23, 24,25,26,27. 
The CBP decreased flow causes splenic bacterial translocation which conditions, these cross 
the intestinal lumen and activate the inflammatory response have different degrees of 
hemodynamic compromise, noting in addition sequential elevations of endotoxin followed 
by elevations in levels of cytokines and these correlate the degree of myocardial 
dysfunction. Endotoxins are potent initiators of the inflammatory cascade causing cytokine 
production, production and complement activation, their presence is associated with the 
development of lactic acidosis, decreased peripheral vascular resistance and left ventricular 
dysfunction. The cardiovascular effects of cytokines are mediated by nitric oxide which 
involves interaction between leukocytes and endothelium and the mechanisms that cause 
these effects are the presence of circulating endotoxin, lipopolysaccharide (LPS) of gram-
negative bacterial cell wall that interact with host cells to promote the release of mediators, 
lipopolysaccharide increases because the immune response by binding to protein carriers of 
LPS forms a complex that is a thousand times more potent to induce the release of tumor 
necrosis factor (TNF) and the union lipopolysaccharide occurs between the CD14 receptor of 
macrophages is that the activation of kinases and TNF. The inflammatory response can be 
maintained by several factors including the production of cytokines such as TNF-alpha (α), 
interleukin 1 (IL-1), IL-1 (beta), interleukin 2 (IL-2), interleukin 6 ( IL-6), interleukin 8 (IL-8), 
interleukin 10 (IL-10), interferon and colony stimulating factors, which may be related to 
postoperative complications. The release of cytokines produce clinical manifestations in 
patients with cardiopulmonary bypass, such as fever, altered level of consciousness that 
occurs microembolisms due to encephalopathy. The crystalloid solutions used to prime the 
pump bypass hemodilution while causing turbulence and osmotic pressure during 
cardiopulmonary bypass cause lesions in the cell membrane of erythrocytes and hemolysis 
eventually causing mainly postoperative bleeding and coagulopathy platelet dysfunction. It 
is possible that renal failure during cardiopulmonary bypass is due to changes in renal 
perfusion during periods of hypotension or, for low blood flow, vasoconstriction and 
microembolism, likewise, hemoglobinuria may also cause significant renal dysfunction as a 
result of hemolysis during CPB, cardiopulmonary bypass can also cause susceptibility to 
infections, Sabick et al found that deep sternal infection occurs in 2% in patients undergoing 
extracorporeal pump versus 0.2% in off-pump patients (p <0.04).28 
Intra aortic balloon counterpulsation (BIAC) 
The intra-aortic balloon counterpulsation is the method used in the treatment of severe 
cardiac dysfunction and potentially reversible in the perioperative and postoperative 
cardiac surgery is indicated in the shock associated with myocardial infarction or other 
complications intractable cardiac ischemia, with or without infarction, ventricular failure 
post CPB, and so on. 
There are two main effects of this device, the first is to increase coronary blood flow 
improved myocardial oxygen availability by increasing diastolic perfusion pressure and the 
second is the blood moves during balloon inflation reduces ventricular work by reducing 
afterload with rapid deflation in systole and thus decreasing myocardial oxygen demand, 
this increases the heart rate up to 20%, thus the signs associated with BIAC surgical 
procedure are: 
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Low cardiac output syndrome, perioperative 
As a bridge to cardiac transplantation 
Acute mitral insufficiency 
Perioperative arrhythmias are difficult to control 
Christeson, showed that the use of preoperative IABP reduced hospital costs and length of 
stay in revascularized and reoperation, Dietl, also reported a stay of 10 days vs. 12 days in 
those with BIAC those who did not have it at a cost average hospital stay of $ 4000 per 
paciente. Although minor complications associated with IABP placement has been 
estimated at 6.5% and higher (vascular surgery and requiring transfusion) of 2.1% is greater 
than the benefit conferred on all preoperative placement to reduce mortality significantly vs 
to who are placed in the postoperative period (mortality 8.8% vs 28.2%, p <0.0001) in 
conclusion, the use of BIAC has increased over the past 10 years, significantly as evidenced 
by the record made in 29, 961 patients England and Canada, where the increase in aortic 
counterpulsation in cardiac surgery in the last 6 years is 47%. 29.30. 
Initial assessment and aost-aurgical therapy (TiPQ) 
There should be a systematic evaluation of the patient immediately on arrival to 
postoperative intensive care unit (TiPQ), communication with the surgical team and 
anesthesia should provide an overview of the intervention performed and the response of 
the cardiovascular system and perioperative hemodynamic treatment and handling of 
medication. Although initially it may focus attention on an aspect of patient status (eg, 
existing arrhythmia on arrival), it is essential to develop a systematic approach to 
evaluation. The patient is fully independent and dysfunction of the elements of support 
systems can be fatal quickly. Surgical dressings must be kept intact during the first 24 
hours in order to control the infection. If handling is necessary for diagnostic purposes 
must follow a strict technique. Upon transfer, the patient should continue with the 
pharmacological management started in the operating room and continued monitoring 
that includes at least fan movement, Electrocardiography digital, non-invasive blood 
pressure (PBIN) and pulse oximetry (SO2). Upon arrival to the ICU should be 
corroborated electrocardiographic tracing displayed on the monitor and make an 
immediate transfer line 12-lead ECG or chest circle when necessary. Capnography 
(PECO2) and central venous pressure (CVP) are measures that must be reactivated 
immediately, it also calibrates the transducer invasive blood pressure monitor confirms 
his bed and his blood pressure is checked immediately after the pacemaker (MCP ) 
epicardial and functionality, if the patient arrives with pulmonary catheter also must be 
calibrated immediately and make a hemodynamic profile to assess their cardiovascular 
status at the time and determine current therapeutic recommendations behaviors common 
pulmonary catheter placement are EF <40%, patients with combined valve implantation 
(aortic-mitral) or severe acute heart failure diagnostic doubt its hemodynamic profile. It is 
important to immediately verify the patency of chest tubes and immediately upon arrival 
quantify pleural drainage at 15, 45 minutes and hourly for the first 24 hours, and assess 
their macroscopic features and clot formation. The ventilatory parameters must be set in 
the next 5 minutes upon arrival and assess the degree of de-recruitment and the need for 
alveolar opening Pa02/Fi02 if their relation ship is less than 200 mm Hg and if their 
hemodynamic status is not compromised, the monitoring hypothermia and its 
management is immediate. During the first 15 minutes should be evaluated central 
venous saturation (SvO 2), arterial blood gases, acid-base status, serum electrolytes (ABG) 
and serum examinations required, such as hemoglobin, platelets, hematocrit, serum 
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electrolytes, coagulation, time Ivy, myocardial enzymes, prealbumin, liver function tests 
(LFT), nitrogenous, Cystatin C, urine sediment and start of urine collection for urinary 
urea nitrogen (NUU), subsequent tests are given in the next 6 hours or before be 
necesario.31, 32,33,34,35 
5. Postoperatively not complicated 
At present, the cardiovascular monitoring is noninvasive and invasive integral part of the 
intensive care critically ill cardiac patient. 
Cardiovascular monitoring 
The proper outcome after cardiac surgery depends on preoperative and postoperative 
status of the myocardium rather than coronary anatomy in the postoperative period is 
uniformly diminished contractility compared to the preoperative magnitude and duration 
of this depression depends on the severity of chronic dysfunction, the presence of recent 
ischemic events, efficacy and complications of operative procedures and the 
intraoperative course. All intraoperative events play a significant role in recovery 
processes are the most important anesthetic management, cardioplegia and 
cardiopulmonary bypass duration. Events and preoperative and intraoperative 
interventions vary in magnitude and duration but in characteristic result in reduced 
myocardial contractility and compliance, which affects the postoperative management 
and eventual evolution. Ejection fraction in the preoperative less than 35%, the presence 
of ischemia or infarction in the immediate preoperative have substantial postoperative 
management, patients with outflow tract obstruction by a disease associated with 
hypertrophic chronic hypertension or stenosis aortic present particular difficulties 
postoperatively. It is always important to optimize left ventricular preload in TiPQ 
evaluated through filling pressures but not always filling pressures adequately reflect 
preload, defined as ventricular end-diastolic volume, so that ideally should be monitored 
with end-diastolic volume index and cardiac index continued, ie in real time. Patients 
with chronic volume overload, as in those with mitral regurgitation are dependent on 
adequate volume resuscitation in these patients the response of blood pressure and heart 
rate are usually a better guide to the proper preload because pulmonary occlusion 
pressure and pulmonary artery pressure are insensitive, except at the ends of 
hypovolemia and fluid overload in this situation, blood pressure and cardiac index can 
significantly change before filling pressures. 36.37 
Ventricular work is a crucial element in the postoperative management of heart surgery, the 
hypertrophic ventricular pressure overload or are intolerant to significant changes in heart 
rate when the heart rate is high, the filling time can be shortened enough to compromise the 
volume of end-diastolic volume and thus cardiac output, in contrast, when heart rate is 
below the time needed to develop the maximum end-diastole, cardiac output may decline 
relative to the low frequency. Assuming that the preload is adequate, a heart rate between 
90 and 100 beats per minute is optimal for a hypertrophic myocardium, where compliance is 
significantly diminished synchronized atrioventricular contraction plays a significant role in 
ensuring optimal preload, so these patients require sinus rhythm or a dual-chamber 
pacemaker. The ventricle with volume overload in contrast, is more tolerant of tachycardia 
and loss of atrioventricular synchrony. When ventricular compliance at the end of diastole 
decrease as a result of increased heart rate, systolic emptying may be better in these patients, 
www.intechopen.com
 
Intensive Care Management of Patients in the First 24 Hours After Cardiac Surgery 11 
sinus rhythm below 75 beats per minute tends to be more deleterious to an abnormal 
rhythm frequencies above 90 per minute, with low heart rates, prolonging the diastolic 
filling time committed ventricular ejection fraction because the ventricle is more dilated. 
Ultimately in ventricles with volume overload tachycardia and loss of atrioventricular 
synchrony can be better tolerated than sinus bradycardia. Determining the degree of 
reduction in contractility admission to TiPQ is problematic, the main contributors to the 
decrease in postoperative contractility including ejection fraction before surgery less than 
35%, CPB time, especially if the duration exceeds 120 minutes. In patients undergoing valve 
procedures, it is advisable to perform intraoperative transesophageal echocardiography at 
the end of CPB as this is useful to assess valve function and ventricular dynamics. If the 
preoperative ejection fraction is greater than 35% and the operative course was satisfactory, 
decrease myocardial compliance in the first 4-6 hours in the unit and then quickly returns 
TiPQ values similar to or better than the preoperative values. Patients with an ejection 
fraction before surgery less than 35%, presence of perioperative ischemia or complicated 
operative course may require a longer time to recover or make permanent dysfunction, 
myocardial depression may persist for an extended period of time. These factors may affect 
the withdrawal of ventilatory support and necessitate the use of oxygen in prolonged, the 
tachypnea may be a reflection of compromised perfusion rather than primary respiratory 
failure. 
Maintaining normal blood pressure is critical in the early hours of postoperative necessarily 
invasive measurement must be continued for at least 24 hours for analysis beat to beat but if 
it is non-invasive measurement must be measured regularly every 5 minutes but the 
objectivity of plethysmographic measurements are reliable non-invasive automatic in the 
absence of intense vasoconstriction and a very high frequency. Class I recommendation, 
level of evidence C. The optimal MAP in the first 6 postoperative hours especially in 
revascularized patients should be 65 to 80mmHg, maintaining adequate tissue perfusion to 
all organs and prevent bleeding at the sites of anastomosis of the bypass. The goal of 
hemodynamic monitoring of critically ill patients is to assess the adequate perfusion and 
tissue oxygenation, using intermittent or continuous measurement of oxygen saturation 
both considered acceptable, although the measurement of lactate may be useful lacks 
precision as a measure of status tissue metabolism in patients with mechanical ventilation is 
recommended central venous pressure of 12-14 mm Hg to offset the increase in intrathoracic 
pressure especially those with PEEP> 5mmHg. A similar consideration is the elevation of 
intra-abdominal pressure (IAP is approximately normal. 5-7 mmHg in critically ill patients) 
as it is inversely proportional to tissue perfusion pressure (PPP) and dependent on the mean 
arterial pressure (MAP) ie: PPA = MAP - IAP. 
The good use in the immediate postoperative period of Swan-Ganz implies a broad 
knowledge of hemodynamics by the doctor for a proper training and constant use of the 
device, much of the value of this catheter for monitoring the hemodynamic status is based 
on their ability adequate to measure pulmonary capillary pressure which we take as a 
measure of left ventricular preload. The subsequent interpretation of a good wedge pressure 
curve are not simple things, implies among other things, the tip of the catheter has been 
placed in a part of the lung that the condition of zone 3, the ball was not over-inflated or 
default, the catheter is floating in the right place and has not migrated back, there is no 
strong auto-PEEP and various other things. However there are many more and more data, 
which indicate that the use of postoperative pulmonary catheter in heart depends on many 
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factors that have little to do with their true indications or the severity of the patient also has 
serious complications observed in studies presented to the placement of a Swan-Ganz 
pulmonary artery in this group of patients where metabolic changes, hypothermia, 
cardioplegia, ischemia or myocardial stunning favor residual arrhythmias, thromboembolic 
events, infections, pulmonary infarction or to knotting of the catheter, not to mention does 
not improve cardiovascular survival in critically ill patients. 
You must have a central venous line and periodically monitor the central venous saturation 
(SvO2) and good availability in the administration of appropriate fluids for resuscitation in 
the first six hours following the early goals of Rivers and colleagues, as therapy guided by 
objectives has been shown to improve survival in critically ill patients susceptible to revival 
under the supervision of personnel in these areas.  
During the first hours must meet the physiological parameters already discussed, however 
those who do not meet these criteria should be reassessed therapeutic conduct, analyze 
ECG, diuresis, PVC, the need to correct up to 30% hematocrit and evaluate the need for 
inotropic or increase in dosage especially if the central venous saturation is <70%, or GC-
invasive measurements have decreased their acceptable ranges. The SvO 2 is a determinant 
and with greater sensitivity in the postoperative monitoring of oxygenation, perfusion, 
oxygen consumption and microcirculatory level, now has shown that goal-directed 
resuscitation, in which this has been a decisive objectives in the first six hours significantly 
decreased cardiopulmonary morbidity and mortality in patients to assess critical to tissue 
oxygenation indirectly: this is defined as adequate oxygen supply to demand, the supply is 
always greater than consumption (VO2), in cases of circulatory shock and severe hypoxemia 
there is a significant fall in DO2 but the VO2 is maintained by the compensation determined 
by the EO2%, which explains a security mechanism that ensures the proper use until it 
descends DO2 a critical point where consumption becomes dependent on the contribution 
anaeróbico initiating cellular metabolism. 38,39 
The use of PiCCO (press contour cardiac output) can continuously monitor cardiac output, 
the variability of pulse pressure and stroke volume. Likewise, estimates of the severity of 
intermittent pulmonary edema, intravascular volume and intrathoracic cardiac chambers, 
two measures related to ventricular preload.  
Electrocardiographic monitoring or driving is important in the first six hours after a stroke 
thoroughly evaluated on admission electrocardiogram to TiPQ, you need continuous 
monitoring of electrical activity and identify arrhythmias or morphological changes that 
warrant immediate management. You also have to periodically assess the proper 
functioning of epicardial pacemaker generator. Management should be initiated when the 
ventricular rate is above 110lat/min. 
Respiratory monitoring 
First of all clinical assessment remains the mainstay in respiratory monitoring, inspection of 
the chest is important from the patient's arrival to TiPQ is important to assess that there is 
synchrony in movements of both amplexación amplexión and thorax as well as observation 
of permeability each of chest drains and their exact position placed by the surgical team 
must verify proper endotracheal tube position, surely the next step is auscultation of lung 
regions in search of clinical syndromes or abnormal sounds that suggest some clinical 
suspicion is necessary to assess respiratory mechanics measurements in our patient by the 
ventilator as well as scheduling parameters. Sets the following startup parameters: 
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Mode: Assist-control (volume or pressure) 
Respiratory rate = 10-15 L / min; 
Tidal volume = 6-8 ml / kg; 
FiO2 = to maintain SaO2> 90%. 
Over 90% of postoperative patients reach TiPQ Units with mechanical assistance in 
breathing, so the generally invasive respiratory monitoring, however, is always important 
clinical evaluation since joining our service to have an initial assessment and observe its 
evolution in the first 24 hours. Not established the need for routine use of PEEP in patients 
without complications due to decreased functional residual capacity (FRC) in these patients 
and atelectasis appear 5 minutes after the onset of anesthesia are not important and no 
impact on arterial oxygenation postoperatively. However, in the first hour is important to 
evaluate the relationship and consider PaO2/FiO2 lung history to give an appropriate 
value, it is also important to rule out existence of residual pleural effusion or pneumothorax 
because both entities are also involved in lowering the ratio PaO2/FiO 2, and evaluated 
these considerations and having a stable hemodynamic status can be performed alveolar 
recruitment maneuver (ARM) is a technique that uses a sustained increase in airway 
pressure with the aim of recruiting collapsed alveolar units, increasing lung area available 
for gas exchange and consequently arterial oxygenation. Recent studies concern the use of 
MRA after cardiac surgery, during which the authors believe that lung function and 
oxygenation are decreased> 20% with the use of cardiopulmonary bypass and the 
inflammatory response with the exponential growth atelectasis. Cardiac surgery with 
cardiopulmonary bypass includes the complete collapse of the lungs, thus, the move will 
improve oxygenation by opening collapsed lung regions. The results of current work 
suggest that alveolar recruitment maneuvers are safe procedure in patients with 
cardiovascular surgery and reduces the frequency of postoperative atelectasis.  
The decline of ventilatory support should generally be within 24 hours, ideally Fast-track 
implementation of the ventilation is the goal in most patients (Fast-track cardiac anesthesia-
FTCA-). The importance of predicting the timing of weaning is that both the early weaning 
as the unnecessary prolongation of mechanical ventilation is deleterious to the patient. In 
addition only with the clinical trial is difficult to predict how successful disconnection 
accurate (50% positive predictive value and 67% negative predictive value) because these 
results justify the implementation of objectives and accurate methods to identify patients 
who are able to adequately of extubated successfully. 
Early extubation is associated with a significant reduction in costs associated with 
mechanical ventilation, there is now several modalities to a quick and safe extubation, 
spontaneous ventilation with pressure support (VPS) with 2 dual ventilation PEEP levels 
(BiLevel) or that pressure release ventilation (APRV).  
Patients extubated within 24 hrs it has decreased PaO2/FiO2 ratio <200 is recommended the 
use of noninvasive mechanical ventilation for 24 hrs demonstrated by Yoshiyuki Takami et 
al, as it must be part of primary treatment strategy in patients with acute pulmonary edema 
in this group of patients and reduces the need for endotracheal reintubation and lower 
mortality when compared against conventional treatment with oxygen therapy in 
postoperative heart patient.  
Pulse oximetry has been used to transfer the patient to the operating room TiPQ unit and 
required at all times to monitor the state of oxygenation does not replace the determination 
of arterial blood gases, however the devices currently are more sensitive and less margin for 
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error, which has gained considerable ground in noninvasive respiratory monitoring. The 
most common cause of inaccurate readings of SpO2 is movement, affects the ability of light 
to travel from the light-emitting diodes (LED) to the photodetector, parkinsonism, seizures, 
tremors, cause problems with detecting saturation with falsely high measurements in low 
perfusion states, such as low cardiac output, vasoconstriction, hypothermia, hypovolemia, 
severe hypotension, particularly in cardiac surgery, the oximeter reading is difficult, 
however, this noninvasive method provides reliable early the decrease in oxygen saturation 
before they show clinical signs of hypoxemia. 
Capnometry capnography and monitoring is a noninvasive method useful in the 
postoperative cardiovascular since it is constantly evaluating the level of carbon dioxide 
(CO2) exhaled and its graphical representation is undoubtedly an important tool in the 
management of mechanical ventilation in the first hours after surgery. Carbon dioxide the 
patient is transported from the cells into the lungs through the venous blood, mostly in the 
form of bicarbonate (HCO3) and dissolved in small amounts in plasma and bound to 
hemoglobin, the amount of CO2 that comes the alveoli is determined by its production and 
flow of venous blood that is, its perfusion (Q), on the other hand, their removal is an almost 
direct function of alveolar ventilation (V). Therefore, the PaCO2 is the result of the 
relationship between ventilation and perfusion: the ratio = V / Q 
1. In the case where the alveolar ventilation equals pulmonary blood perfusion, PaCO2 is 
very similar to PaCO2 in these cases changes in the PaCO2 almost exactly reflect those 
observed in PaCO2. 
2. In cases where ventilation is inappropriately high with respect to the infusion, ie there 
is a high degree of "dead space" (VD), PaCO2 is considerably lower than PaCO2. 
3. In cases where the ventilation is decreased in relation to infusion, PaCO2 is close to the 
values of PCO2 in venous blood, ie the PvCO2, and results in a V / Q low. This occurs 
in those clinical situations in which the airways or alveolar sick or increased pulmonary 
blood perfusion. 
As evaluated in the above three points the lungs are not physiologically homogeneous and 
therefore carbon dioxide at the end of expiration (ETCO2) is the average of the mixture of all 
different types PaCO2 alveoli. It's called PaCO2-ETCO2 gradient to the difference between 
arterial CO2 pressure and the pressure of CO2 in the alveoli (ETCO2), which normally is 1-5 
mmHg. This small difference is due to the small dead space that exists in normal conditions. 
But knowing the physiological concepts, translation in the immediate postoperative clinic 
may be: 
 A ETCO2 of 0 usually means the patient is not breathing, however, can also be the 
result of a malfunctioning fan or a disconnect from it. 
 The decrease in ETCO2 suggests a decreased production of CO2, hypothermia or a fall 
in transport, low cardiac output, excessive alveolar ventilation, hyperventilation or a 
malfunctioning fan. fig 6 
 Increased ETCO2 may be the result of excessive production of CO2, hyperthermia or 
sepsis or a decrease in alveolar ventilation  
Arterial blood gases are essential to making the postoperative management of blood gases 
were performed on all patients from their initial arrival and subsequent to any adjustment 
or correction fan electrolyte and acid-base status, interpretation of blood gases is sometimes 
difficult; laboratory results must always be studied in light of the clinical picture, by the 
systematic approach to each of the values. In the critically ill patient post-operative heart 
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surgery is also necessary to know the values of venous blood gases. The determination of 
arterial and venous blood gases provides three basic values through direct measurement of 
the respective electrodes: 
1. Partial pressure of oxygen dissolved in plasma, PaO2. 
2. Partial pressure of carbon dioxide dissolved in the plasma, PaCO2. 
3. The degree of acidity or alkalinity of the plasma pH. 
The PaO2 is the rate of oxygenation of the blood an indicator of the intensity of the 
presence of molecular oxygen dissolved in plasma, is the expression of the efficiency of 
alveolar ventilation-perfusion and alveolar capillary diffusion normal to achieve the 
transfer oxygen from inside the alveolus to pulmonary capillary blood. The PaCO2 is a 
ventilation parameter also reflects the respiratory component of acid-base and is a highly 
reliable method that reflects without confusion or error, unless you have a fan failure or 
bad programming environment with respect to individual clinical Patient postoperados.40, 
41,42,43 
Renal monitoring 
The clinical value in the immediate postoperative period is important because the simple 
quantification of urine schedule can objectively evaluate renal function, however there are 
several circumstances where the patient usually attends with minimal deterioration and 
time indicated by decreased urine output, factors are multi-age, prior renal impairment, 
intravascular volume cash cytokines by CBP, controlled hypotension, bleeding, and so on. 
The incidence of acute renal failure (ARF) in cardiac surgery with cardiopulmonary 
bypass, between 1% and 45%, and in most schools in a 1% to 15%. The incidence of severe 
ARF that required renal replacement therapy techniques, the work varies between 1% and 
11.1%, thanks to a study by Charujas and colleagues demonstrate and validate a "ARF 
score" in patients undergoing heart surgery and determine the risk of postoperative renal 
failure in taking a score: 1 to 17 than to predict the risk of acute renal failure expressed in 
percentage.  
The CBP has also been involved for many years in the genesis of renal damage associated 
with cardiac surgery, initially manifested by microscopic or gross hematuria depending on 
the severity, though studies of the last fifteen years, using sensitive techniques to identify 
kidney damage have suggested greater importance of perioperative generator impairment 
and acute renal failure, as opposed to possible damage of CPB. Most of these studies have 
been performed in elective postoperative patients with normal preoperative renal function, 
recent studies comparing off-pump coronary surgery versus conventional coronary surgery, 
show no differences in postoperative renal damage, however the valve patients have been 
considered within the group at high risk of kidney damage. So today in the early hours 24 
hours urine volume remains the most reliable parameter of renal impairment and prayers 
whatever their origin (hypovolemia, nephrotoxicity, ischemia, contrast, etc). 44,45,46,47  
Metabolic monitoring 
Hyperglycemia in the perioperative period is associated with increased morbidity, 
decreased survival and increased costs. A number of observational studies have shown that 
improved control of glucose levels in diabetic patients undergoing coronary 
revascularization improves the outcome. Van den Berghe et al demonstrated in surgical ICU 
patients, 63% of whom were postoperative cardiac surgery, the control of glucose 
concentrations of 80-100 mg / dl was associated with a relative decrease in mortality over 
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40% when compared with controls. This study has been criticized for lack of blind control, 
administration of high doses of glucose control and high incidence of hypoglycemia. The 
current recommendation is to try to keep blood glucose below 150 mg / dl, this was 
secondary to a study called normoglycemia in Intensive Care Evaluation Survival Using 
Glucose Algorithm-Regulation (NICE-SUGAR) used to test the hypothesis that intensive of 
blood sugar reduces mortality 90 days in this study showed higher mortality from severe 
hypoglycemia. Because polyuria in the early hours, the release of antidiuretic hormone and 
hyperaldosteronism that characterizes the patient operated on with CPB, it is common the 
presence of hypokalaemia which must be corrected for values greater than 4.0 mEq / L, just 
as occurs hypomagnesemia should be corrected usually there is usually no changes in 
serum calcium or other ions that require correction. 
The dilutional hyponatremia type being increased total body sodium, the use of mannitol 
and / or furosemide during CPB produces a polyuria in the first two to three hours 
postoperatively INSTANT that can reach 1000 ml / hour, with a tendency to normalize 
within hours, the usual consequence is the need to infuse fluids resulting hypovolemia. 48.49 
Neurological monitoring 
It is essential in the first 24 hours because it is not uncommon to find deficits in different 
degrees and which are generally grouped into cognitive dysfunction, which is the most 
common disorder and unnoticed, and that their identification will be necessary to carry out 
mini-mental and demonstrate an early deficit and time of their higher mental functions. All 
patients coming to the unit with residual sedation TiPQ so within the next 6 hours there is a 
95% elimination of sedatives, since coming patients should be evaluated clinically to assess 
the integrity of the stem bark and well-get a first impression to rule out diagnoses and 
cerebral ischemic event or bleeding. In patients who quickly integrates a focus 
fasciocorporal study should be completed image and a more detailed review to have an 
early management and prevent secondary damage. 50.51 
Moreover, patients with prolonged CPB tend to have greater involvement of 
cardiorespiratory function and hemodynamic instability preoperatively intraoperative 
surgery more complicated, hence the increased incidence of neurological disorders may 
be related to these factors rather than the CPB time, now happens with hypotension and 
cerebral hypoperfusion which is another postulated mechanism of neurological damage. 
The CBP is under hypothermia and anesthesia, both of which lower the cerebral 
metabolism and thus cerebral blood flow as there is less demand on the other hand, 
hemodilution decreases blood viscosity by decreasing its resistance to move, so lower 
blood pressure can keep the same cerebral blood flow. Thus, it alters the autoregulation 
curve of cerebral blood flow may keep it even with blood pressures of 50 to 60 mm Hg, 
studies measuring regional cerebral blood flow in patients during CPB have shown that 
blood pressure can reach 50 mm Hg without altered cerebral blood flow. Moreover, the 
flow can reach 19 cm 3 per 100 grams of tissue per minute without psychometric 
alterations detected between pre and post operative. Glasgow is interpreted evaluation at 
baseline and 6 hours by issuing a neurological assessment, monitoring with bispectral 
index (BIS) in patients who have to initiate a secondary sedation is necessary to identify a 
level of sedation adecuado.52, 53 , 54 
Hematologic monitoring 
Hematologic monitoring after surgery is associated with anemia hemodilution and blood 
loss, the minimum necessary use of blood products has shown improvement in morbidity 
www.intechopen.com
 
Intensive Care Management of Patients in the First 24 Hours After Cardiac Surgery 17 
and mortality in recent years. This consideration has resulted from recent meta-analysis and 
evidence-based medicine, evidence shows the association of adverse effects such as 
increased costs, morbidity and mortality especially in the group <65 years so even 7.5gr 
hemoglobin can be well tolerated and no increased risk increase in elderly patients without 
ischemic but the minimum allowed is 8.5 grams, although a large number of scientific 
publications are those who prefer to have an algorithm in relation to individual patient 
characteristics as shown in the table below . The indications for transfusion in patients with 
coronary disease are valid when hypovolemia has been corrected, optimized hemodynamics 
and oxygenation after correction tachycardia. 55,56,57 
It is common in the postoperative cardiac surgery hours uncomplicated run smoothly. At 
approximately 36 hours the patient can be transferred to a general room with telemetric 
control. 
6. Complicated postoperative 
Cardiovascular 
Hypotension and hypoperfusion injury may condition not directly related to the surgical 
procedure and include cardiac tamponade, a new myocardial ischemia, tension 
pneumothorax, hemothorax or significant bleeding related to arterial cannulation. Rarely 
produce acute thrombosis of a graft or coronary embolization. The electrocardiogram 
(ECG) may be of diagnostic aid because it is expected that the initial postoperative ECG 
changes does not show or reveal abnormalities preoperatively limited ST-T. If there are 
significant changes in ECG repeated, should be thought of an occlusive lesion of one of 
the grafts. 
In the presence of suspected acute ischemia should indicate intravenous nitroglycerin, the 
risk of a perioperative myocardial infarction is present from the preoperative to the hospital 
and even after the diagnosis of acute myocardial infarction (AMI) presents difficulties in the 
perioperative You must have a combination of ECG, cardiac enzymes and echocardiography 
can occasionally make the diagnosis. Frequently observed nonspecific ECG changes a large 
percentage of patients have an increased enzyme and troponin I (TnI) generally exceeds the 
levels observed in AMI unrelated to cardiac surgery. The loss of graft thrombosis has been 
reported in up to 10% of grafts in the first week in the hours following the surgery, aspirin 
and possibly clopidogrel appears to reduce the prevalence of AMI diagnosis although 
postoperative postoperative AMI is difficult itself has a significant effect on morbidity and 
mortality in the long term. 
Arrhythmias 
Low cardiac output syndrome 
The low cardiac output syndrome (LCOS), is characterized by decreased performance of 
cardiac function where the cause may damage myocardial and cardiogenic shock condition 
corresponds to a failure in the balance between central cardiac pump and control 
components peripherals, including: a) the tone of the peripheral circulation and b) 
neurohumoral regulators of vascular tone, with the arrival insufficient oxygenated blood to 
peripheral tissues to meet metabolic needs, their presence is associated with high mortality 
at that requires immediate diagnosis and treatment. The multiple causes can produce or 
aggravate this syndrome can be grouped, for descriptive purposes, the following pathogenic 
mechanisms: 
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1. Reduced preload. The major cause is the leakage of fluid into the interstitial space, 
excessive bleeding, polyuria, the use of high levels of positive end-expiratory warming 
excessive vasodilator drug use, cardiac tamponade, and so on. 
2. Increase in afterload. It can affect both the left and right ventricle. in the cause of 
increased afterload are systemic hypertension, pulmonary hypertension, the 
replacement of the mitral valve in mitral regurgitation, etc.. 
3. Reduced contractility. The main causes of decreased contractility are perioperative 
AMI, drugs with negative inotropic effect, the phenomena exaggerated ischemia-
reperfusion during aortic clamping, and so on. In relation to the phenomenon of 
ischemia reperfusion is important to note contractile deterioration often not 
immediately apparent to the patient's admission to the ICU. In these cases, there is a 
period of normo-or hyper ventricular early after reperfusion. This period is short 
(hours) and is followed by a gradual depression of systolic function, leading in many 
cases to a false sense of security in the early postoperative hours, when this 
phenomenon is unknown. 
4. Changes in heart rate and heart rate. Are due to extreme bradycardia, supraventricular 
or ventricular tachyarrhythmias and impaired high-risk condition. 
5. Metabolic and electrolyte. Acidosis, hypoxemia, hypo-or hypercapnia, hyperkalemia, 
hypocalcemia and may contribute to the development of this syndrome. 
6. Inadequate surgical management. Sometimes not achieved the expected result from the 
technical point of view and this can generate a low output syndrome, such as poor 
condition can bridge aortocoronary junction in myocardial revascularization surgery, 
prolonged pump time with poor poor systemic perfusion and hypothermia induced, 
the presence of a residual stenosis in mitral commissurotomy, miss-match of prosthetic 
valve replacement or plasty, and so on. 
The diagnosis of low cardiac output syndrome after surgery can be established through the 
clinic or by hemodynamic monitoring. Hypotension is the warning sign and used more 
widely, however, patients with moderate decrease in cardiac index may retain acceptable 
levels of low systemic blood pressure which minute volume is high or normal. Oliguria is 
the most common signs of urinary volume monitoring is time and calculate the minute 
volume through the renal plasma flow and rhythm of diuresis, but lacks specificity. No 
doubt the hypothermia of the extremities and the temperature difference between central 
and extremity: these signs are not very useful in the immediate postoperative period 
because patients usually come to body temperature, cardiovascular recovery with low and 
sometimes remain so for several hour, despite attempts to overheat. In the first hours after 
surgery are patients with marked vasomotor instability (vasoconstriction - vasodilation) for 
which no specific capillary filling. On the other hand in the first hours after surgery can be 
found lactic acidosis, which in many cases does not reflect the present situation, but 
situations of decreased perfusion in the operating room occurred body, markedly 
decreasing the diagnostic and prognostic value with other medical and Finally, the decrease 
in mixed venous saturation, this parameter depends on cardiac output and oxygen 
consumption level of the tissue, so in the first 60 minutes is more specific cardiac output. 
Due to the low sensitivity and specificity of symptoms from the first sign of consensus 
definitions in cardiovascular recovery, recently published, is required to make the clinical 
diagnosis of low cardiac output syndrome, patients present simultaneously at least 2 of the 
following criteria: 
Hypotension (systolic blood pressure below 90 mmHg). 
Oliguria (urine output less than 0.5 ml / kg / hr). 
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The hemodynamic evaluation allows continuous monitoring of cardiac function 
postoperatively, being indispensable implementation in this particular group of patients. 
This is done by direct measurement of cardiac output by thermodilution technique. Authors 
such as J. Kirklin consider being in the presence of low cardiac output when cardiac index 
less than 2.2 L/min/m2 in the early hours after surgery and less than 2.4 L/min/m2 in the 
first postoperative day, other authors consider the value 2.0 L/min/m2 index of heart as the 
limit for the diagnosis of low cardiac output syndrome, with values between 2 and 2.5 
L/min/m2 cardiac index usually require therapeutic intervention, whatever its value must 
be accompanied by systemic vascular resistance values normal or elevated, for 
differentiation vasoplegic syndrome that presents with decreased systemic vascular 
resistance. The radionuclide ventriculography with Technetium 99 is an excellent diagnostic 
tool, with it you can obtain the ejection fraction as much of the left ventricle of the right 
ventricle, and allows cardiac tamponade diagnosed by the presence of pericardial blood or 
clots in relation to Echocardiography its main drawback is to obtain an acceptable acoustic 
window in this group of patients, however these problems have been solved with 
transesophageal echocardiography. LCOS mortality is very high, the study CONAREC III 
mortality of patients suffering from low cardiac output syndrome was 44.7%, compared to 
those patients who did not suffered and whose mortality was only 4.9% in the same study 
when considering all the excuses of death, this syndrome was the most frequent (28.9%) in 
patients undergoing coronary bypass surgery. Another study observed the ESMUCICA 
un12% mortality in CABG and valve surgery in 25-45%) and ESMUCICA II (26% mortality 
in valvular). 
The therapeutic management should follow a similar pattern of the pathogenesis stating: 
a. Optimize preload 
b. Optimizing afterload 
c. Optimizing the pace and heart rate. 
d. Increase inotropy. 
The optimal preload for each patient is different and depends on the heart for each patient 
and how they estimated. When you need to optimize the preload is used intravascular 
volume expansion with either colloids, crystalloids or both, while, as if what is required is a 
decrease in preload is done with diuretics, vasodilators, with predominant effect in the 
venous bed as nitroglycerin, mechanical ventilation with PEEP or hemofiltration if the 
patient is oliguric renal failure. 
Afterload also depends on heart disease for each patient and if you have any other special 
situation. The most commonly used drugs to reduce vascular resistance and therefore 
afterload are vasodilators with predominant effect on the arterioles, such as sodium 
nitroprusside. Another important therapeutic elements are warming persist in hypothermic 
patients, sedation and analgesia in patients who have pain or anxiety they generate strong 
isometric muscle contraction, and oxygen in varying concentrations in those with 
hypoxemia and pulmonary vasoconstriction bed with increased pulmonary vascular 
resistance and consequently the right ventricular afterload. To get the rhythm and heart rate 
can be used atrial pacing in case of a sub-optimal heart rate in sinus rhythm and normal 
atrioventricular conduction, ventricular pacing in cases of atrial fibrillation with low 
ventricular response, and sequential pacing, atrioventricular case of complete 
atrioventricular block. The presence of tachyarrhythmias can be managed with drug 
therapy, over-stimulation or cardioversion shock as appropriate. 
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Commonly used catecholamines such as dopamine, dobutamine, isoproterenol, 
epinephrine, norepinephrine and inotropic catecholamines not milrinone and 
levosimendan, being necessary in many cases the combination of more than one. 
Catecholamines, particularly dopamine are the drugs most often used and indiscriminately 
without taking into account many times the preload. The most important are the 
catecholamines and phosphodiesterase inhibitors, there are few data concerning the use of 
levosimendan. these agents have proven effective in improving myocardial contractility or 
heart rate or both catecholamines are more potent chronotropic and inotropic agents 
determine side effects such as increased myocardial oxygen consumption of the 
myocardium, tachycardia, arrhythmias, and increased in afterload can make your job 
difficult. Β-adrenergic receptors may also be downregulated in patients with previous heart 
failure. This has increased the interest in the use of inhibitors of phosphodiesterase III and 
more recently, the calcium sensitizer levosimendan. In a study by Labriola et al. Nijhawan et 
al.) Drug compared to placebo in patients with low cardiac output syndrome after surgery, 
in which documented an increase in cardiac output and ejection fraction and a decrease 
systemic vascular resistance in patients treated with levosimendan. Gillies et al. Conducted 
a systematic review of the literature on the use of inotropic agents in patients with cardiac 
surgery, in which certain recommendations were documented, each with a particular level 
of evidence. 
Respiratory 
Respiratory dysfunction in postoperative heart surgery patients is a common problem 
that results in a significant increase to 25% mortality and significant morbidity with 
impact on cost and hospital stay, atelectasis is a frequent occurrence in the immediate 
postoperative period The incidence of atelectasis in the postoperative period of 40 to 
cardiac 70%, the term is derived from Greek: Atel and ektasis mean incomplete expansion 
of a segment or lobe is characterized by volume loss and collapse of alveolar region 
manifested radiographically as an area opacified. The severity of atelectasis increases with 
more time to pump, more bridges and prolonged ischemia, the opening of the pleura, 
phrenic nerve injury, intraoperative and very low temperatures. Thoracotomy alters lung 
function by shallow breathing (restrictive functional pattern), and vital capacity may be 
reduced by up to 45 to 70%, the pain diminishes deep breath and a cough can lead to 
ineffective with the consequences in lung mechanics and bronchial hygiene. Another 
important factor is the presence of atelectasis, diaphragmatic paralysis caused possibly by 
phrenic nerve injury caused by surgery or by the use of topical agents or cold 
cardioplegia. Decubitus position maintained, leads to changes in regional distribution of 
ventilation and perfusion of the lung, lung inflation decreases along a vertical axis from 
ventral to dorsal supine and when spontaneous breathing begins immediately after 
surgery and in the supine position ventilation is distributed mainly dependent areas of 
the lung. In contrast, during mechanical ventilation, this pattern changes and the 
distribution of ventilation is primarily aimed at non-dependent areas in both positions, 
therefore, the subsidiaries tend to collapse. Studies have shown that prone position 
ventilation becomes more homogeneous. Mechanical restraint of ventilation is produced 
by several factors explain such as bronchial secretions accumulating in dependent areas, 
pleural effusion or dysfunction of chest drains in the first hours after surgery. Alveolar 
recruitment maneuver is a technique that uses a sustained increase in airway pressure 
with the aim of reducing atelectasis by recruiting collapsed alveolar units, increasing the 
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lung area available for gas exchange and consequently arterial oxygenation. Different 
methods are used alveolar recruitment in the postoperative patient, it is important to 
know that before the maneuver is to have an adequate intravascular volume and residual 
sedation after surgery. Ventilatory strategies proposed to achieve alveolar recruitment in 
surgical patients are based on the use of pressure (PEEP or CPAP) ranging between 20 
and 40 cm H2O for varying periods of time. The effects of positive end-expiratory should 
be monitored continuously, as some of the side effects include decreased venous return by 
increasing the average pressure of the airways, impaired lung perfusion overdistended 
areas (increase dead space), increased pulmonary vascular resistance and right heart 
dysfunction, barotrauma and impaired renal blood flow, which are frequent causes of 
hemodynamic compromise in critically ill patients with cardiovascular disease and those 
with intravascular volume deficit. Pleural effusion is frequently observed in the 
immediate postoperative period, but a considerable percentage persist for more than 30 
days, the incidence is 41-87% in postoperative patients, although most are not significant 
pleural effusions, a study of 602 heart postoperative patients showed pleural effusion in 
63%, more than 30 days but less than 5% need thoracentesis for resolution in those 
patients who had more than 5 days chest drains pleural related to infections associated 
with atelectasis and ipsilateral lung infection, said box by fever, productive cough and an 
alveolar infiltrate on chest radiograph. It is important to differentiate whether it is indeed 
a spill transudate or if there is a pulmonary complication due to an infection with a 
pleural early. To make this distinction using the criteria of Light, which are more sensitive 
at identifying exudates, they meet at least one of the following criteria: (transudates none) 
1. Relationship between pleural fluid protein and serum 0.5, 
2. Relationship between pleural fluid LDH and serum 0.6, 
3. In pleural fluid LDH greater than the 2 / 3 parts of the upper limit of normal for serum 
LDH. 
Other proposed criteria for an exudative pleural effusion are: 
4. Cholesterol> 43 mg / dl, 
5. Gradient-pleural serum albumin less than 1.2 g / dl. 
The thoracic duct that enters the thorax through the right diaphragm and flows into the 
left subclavian vein, has collateral lymphatic sometimes can be injured during surgery 
and result in a chylothorax. This pleural fluid milky-white at times and some colored 
(yellow or red) in other, has high content of lymph (chylomicrons), with a triglyceride 
level above 100 mg / dl and cholesterol below 200 mg / dl , treatment includes not 
remove the chest tubes because the fistula may close spontaneously in the thoracic duct 
short time, starting with parenteral nutrition for 10 to 14 days to reduce the production of 
intestinal lymph and thereby reduce the flow through the thoracic duct. If despite these 
measures fail to control the chylothorax, pleurodesis can be performed. Injury or acute 
progressive respiratory insufficiency (ALI / ARDS) is a multifactorial process of 
respiratory damage from pulmonary or extrapulmonary origin and is defined by the 
European-American consensus.  
In patients with postoperative heart surgery the incidence is 5 to 20% depending on the type 
of surgery, severity, time in surgery, bleeding, age, EuroSCORE, comorbidities, and so on. 
In elderly patients shows the highest incidence due to low physiological reserve and are 
more likely to have postoperative complications, the impact of gender remains 
controversial, although female gender was not shown to be an independent predictor of 
LPA in a large study recent cohort, two small studies identified a strong association between 
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female gender and the incidence of ALI after cardiac surgery. Vascular risk factors are 
independent predictors of LPA include diabetes, kidney failure, hypertension. These 
markers of systemic atherosclerotic disease are associated with an increased risk of major 
complications. Preexisting renal insufficiency is a strong predictor of ALI (OR, 2.3), which 
confirms the findings of several studies, increased atherosclerotic burden associated with 
renal failure. Chronic obstructive pulmonary disease (COPD) identified preoperative was 
also an independent risk factor, confirming that patients with COPD who are undergoing 
valve surgery or surgery RVM have two or three times the chance of LPA in severe COPD 
has been associated with excess postoperative mortality in patients with MVR. 
Pathophysiological observed that lung damage is mixed but the most important finding in 
the lungs during the early stages of ALI / ARDS is the presence of severe pulmonary edema 
secondary to increased permeability of capillary endothelium and alveolar epithelial barrier 
of . Simultaneously, increased pulmonary vascular resistance as a result of thromboembolic 
events and reflex vasoconstriction, these morphological characteristics are a complex 
reaction of the lung to different nosological agents and processes and not related to the 
nature of the causal process. During mechanical ventilation in the immediate postoperative 
behavior is rest to follow by pulmonary alveolar protection strategy as ALI / ARDS is a 
syndrome characterized by loss of functional residual capacity, increased lung and short 
circuits refractory hypoxemia FiO2. The standard or optimal tidal volume is difficult to 
determine, because in the inflamed lung or ALI / ARDS alveolar pressures each area has 
specific and requires its own level of PEEP to keep open during expiration. The alveolar 
pressures and volumes that can reach areas not dependent overdistended lung, are often 
insufficient to ensure the recruitment of regions dependent edema and atelectasis by 
maintaining recruitable lung areas open, there is distension of the healthy areas of the lung, 
it is explained that the regional compliance of the lung are different as well as mentioned 
Gattinoni. 
Postoperative bleeding 
One of the most frequent complications encountered in the management of patients, 
approximately 20% of patients present with significant bleeding and only 5% required 
reintervention. Predictive factors for bleeding include age, renal failure, cardiopulmonary 
bypass time, liver failure, hypothermia, secondary fibrinolysis, NSAIDs, etc; bleeding 
contributes to more days of ventilation hospital stay and mortality. 
The definition of excessive bleeding in postoperative patients occurs in 5% -10% 
approximately and only 3% required reoperation, bleeding, and reoperation are 2 
independent predictors of poor prognosis. In those patients with postoperative bleeding can 
be divided into two categories: surgical bleeding (bleeding venous layer anastomosis, 
sternum, anywhere stitches), non-surgical bleeding (caused by coagulopathy). 
Risk factors for bleeding are preoperative such as pharmacologic agents (thrombolytic 
PTCA, antiplatelet drugs, anticoagulation) in the case of ASA should be discontinued 5-7 
days before surgery and anticoagulation is recommended to have INR <1.5, five days prior 
to surgery, vitamin K malabsorption, liver disease due to decreased synthesis of clotting 
factors, SLE, amyloidosis, prior chemotherapy, and so on. 
Intraoperative risk factors are: pump bypass, hypothermia, use of heparin during 
cardiopulmonary bypass generation of fibrinolytic activity and postoperative risk factors 
known are octogenarians, non-elective surgery, low BMI, CPB> 150 min, grafts ≥ 5, surgical 
reintervention. 
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During the first 6 hrs of PO should immediately obtained objective results of platelet count 
and coagulation, for early medical or surgical management, clinical criteria is in relation to 
the following table. 
In the management of patients with heavy bleeding PO should commence administration of 
blood products such as red cell concentrates without doubt the goal is to maintain the 
optimum level in arterial blood content [CaO2 = CaO2 = Hb (g/100ml) x 1.34 (ml O2 / g) 
x% SaO2 + (PaO2 x 0.0031) = ml blood O2/100ml)]. They are prepared with 300 ml volume 
with low WBC (<5x106 cells) to reduce alloimmunization and avoid possible TRALI or lung 
damage. Cell salvage, the process by which collects a patient's own blood during surgery for 
later transfusion in the same patient is a reliable alternative to donor blood transfusion 
when needed. We found 23 studies investigating the effectiveness of cell salvage in cardiac 
surgery, conclude that apparently there is insufficient evidence to support the use of cell 
salvage in cardiac surgery but the methodology in the studies were flawed and may be 
biased. 
Alterations in the number or function of platelets may have effects ranging from a clinically 
insignificant prolongation of bleeding time to large defects of hemostasis, platelet 
transfusion is usually required when it decreases the count: <50,000, is individualized 50-100 
the case and over 100,000 were transfused if the time of Ivy is more than 10 minutes with 
continued bleeding. Can be obtained by platelet concentrates (40-70ml) or platelet apheresis 
(200-300ml). 
The use of fresh frozen plasma in postoperative patients offers all the clotting factors and 
plasma proteins needed to improve the prothrombin time and clotting better ensure 
hemodilution coagulopathy, caution should be exercised in bleeding secondary to heparin, 
as a source ATIII natural and should not be used prophylactically. To replace clotting factors 
to be used a dose of 10 to 20 mL / kg, which could increase the concentration factor by 20% 
immediately after infusion. 58,59,60 
The cryoprecipitate is a concentrate of plasma proteins of high molecular weight cold rush 
its volume is approximately 15 to 20 mL after removing the supernatant plasma containing 
concentrations of factor VIII: C (procoagulant activity), 80 to 120 U; factor VIII: vWF (von 
Willebrand factor), 40 to 70%, fibrinogen, 100 to 250 mg, and Factor XIII, 20 to 30%. 
Most of the work with hemostatic agents were designed to assess the therapeutic efficacy 
and to assess potential toxic effects, so that there are still definite data on the safety of 
hemostatic agents. Many studies on these agents have used perioperative blood loss and 
other parameters with endpoints of little clinical importance, whereas other studies did not 
have enough power to evaluate the clinical outcome of importance, such as mortality or 
need for reoperation. 
Pharmacological agents that decrease postoperative bleeding are desmopressin is a synthetic 
analogue of natural vasopressin, with the advantage of having less vasoconstriction, is 
recommended for use in the immediate postoperative hemostatic, unlike aprotinin has 
fewer side effects such as anaphylaxis, thrombosis and renal failure. Aprotinin has been 
used in recent times but because it is a bovine protein, there is an increased risk of 
anaphylaxis, especially if you already had previous exposure, and its cost is higher. When 
used at low doses acts as antidiuretic hormone and is 10-20 times the dose that increases 
hemostatic function and plasma levels of factor VIII, von Willebrand factor (vWF) and tissue 
plasminogen activator (tPA), releasing these factors endothelium and liver. Also observed 
increased platelet aggregation, the result is the shortening of bleeding time. Administered 
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IV (0.3ug/Kg), SC (0.3ug/Kg) but for obvious reasons dministration IV is recommended in 
postoperative patients. The best response is expected between 30-60min after parenteral 
administration. 
Inside are antifibrinolytic drugs: aprotinin (a direct inhibitor of the fibrinolytic enzyme 
plasmin) is the only drug approved by published and the Food and Drug Administration 
(FDA) to minimize transfusion requirements in coronary bypass surgery, directly inhibits 
the fibrinolytic enzyme plasmin, plasma kallikrein, tissue trypsin and activated coagulation 
factor XII, the highest recommended dose is> 700mg. 
 Are also used tranexamic acid and aminocaproic acid, but have not been approved by the 
FDA for this indication, their mechanisms of action are the first to inhibit the binding of 
plasmin to fibrin occupying the binding sites of lysine of the proenzyme plasminogen and 
the second is the same mechanism of action, but 10 times more potent. Doses are 10-30g and 
maintenance 1-3gr/hr and the second 3-10gr with 20-250mg/hr maintenance. 
There are reviews of meta-analysis on the effectiveness of antifibrinolytic agents compared 
with placebo, aprotinin or tranexamic acid, but not aminocaproic acid, reduced the need for 
blood transfusion by 30% and saved about 1 unit of blood per operation. There was no 
difference in efficacy between regimens with high or low doses of aprotinin, while varying 
doses of tranexamic acid and aminocaproic's not possible to assess the relationship between 
dose and efficacy. As for the most relevant clinical events, the relative risk of reoperation for 
excessive bleeding was significantly reduced in patients receiving aprotinin, compared with 
those receiving placebo, although the mortality rate remained unchanged. Both tranexamic 
acid and aminocaproic acid significantly decreased these events. Therefore, the results of the 
work checked and reviews indicate that antifibrinolytic drugs are effective hemostatic 
agents in cardiac surgery. Reductions in transfusion requirements and reoperation for 
bleeding seem to be confirmed by the narrow confidence intervals of likelihood ratios, 
indicators of relative risks. There were no sufficient data on the effectiveness that allow 
definitive conclusions regarding the use of antifibrinolytic agents in other situations. 
61,62,63,64,65,66,67 
While other review reports that aminocaproic acid and tranexamic acid are safe, it is 
noteworthy that the works included were smaller than the jobs studied aprotinin. Therefore, 
the authors say, the safety data are not reliable, especially with regard to thrombosis. 
Currently, the Blood Conservation using Antifibrinolytics: a randomized work in a 
population submitted to cardiac surgery (Randomized Trial in a Cardiac Surgery 
Population) or BART, which is still enrolling patients, is designed to enroll 2970 patients 
with indications for cardiac surgery high risk, to determine whether aprotinin is superior to 
tranexamic acid or aminocaproic acid to reduce the risk of massive postoperative bleeding. 
Secondary endpoints were overall mortality and adverse effects such as cardiovascular 
disease and kidney failure. For all available data, the authors argue that the evidence that 
aprotinin reduces perioperative bleeding and immediate postoperative transfusion 
requirement is sound. However, note that despite the large number of clinical trials that 
have addressed the drug, its effectiveness in reducing the need for reoperation has just 
emerged from reviews and lack of evidence about its effect on mortality. 68,69,70 
Recombinant activated factor VII (rFVIIa) acts locally at the site of tissue injury and 
alterations of the vascular wall by binding to exposed tissue factor, generating small 
amounts of thrombin sufficient to activate platelets. The activated platelet surface can then 
form a template on which rFVIIa half the direct or indirect activation of coagulation to 
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generate thrombin in the end much more and convert fibrinogen to fibrin. The clot is 
stabilized by inhibition of fibrinolysis, secondary to activation of the inhibitor of thrombin-
activatable fibrinolysis mediated by rFVIIa. The availability of rFVIIa has expanded 
treatment options for acute bleeding in hemophilia patients. This drug is not a panacea, but 
it has efficacy in patients with trauma and excessive bleeding resistant to other treatments. 
However, the encouraging results obtained so far must be confirmed by other studies, are 
also necessary cost-effectiveness studies, as it is an expensive drug. The authors recommend 
to take with caution the results of studies recognized even before considering the evidence 
as a guideline. We have tried to increase the power and efficacy of rFVIIa by molecular 
engineering acting on DNA, but no studies. 71,72,73,74,75 
Perioperative myocardial 
Although virtually all patients have some degree of increase in cardiac enzymes after 
surgery. The perioperative myocardial infarction is one of the most serious complications 
after CABG (RVM), an incidence of 5-20%, and is associated with significant morbidity and 
mortality in the post-surgical high. The pathogenesis of IPO vasa in the various mechanisms 
by which the placement of coronary artery bypass bridges leading to myocardial necrosis: 
The most common is acute occlusion of the hemoducto, twist it, subtotal graft stenosis or 
spasm, saying recent articles The presence of collateral arterioles protects perioperative 
stroke patients. 
The perioperative myocardial infarction (IPO) type 5 belongs to heart and is defined 
according to the latest consensus established in 2007 by the AHA / ACC as an increase of at 
least 5 times the baseline or reference biomarkers, along with the emergence of new q waves 
left bundle branch block on electrocardiogram, or coronary angiography showing acute 
occlusion of hemoductos and imaging evidence of recent loss of viable myocardial tissue. 
According to Thielmann, the increase in markers of myocardial damage, can be used to 
discriminate between perioperative stroke related to the placement of coronary artery 
bypass bridge, or another cause. So analyzing 3308 patients with MVR, I conclude that the 
94 who underwent coronary angiography, 56 had stroke related to the placement of 
coronary artery bypass bridges, 38 was not related to the procedure. Levels of troponin I, 
rather than CK / CK-MB rose significantly in the first group with respect to the second, 
considering the troponin I as the best marker to discriminate between IM surgery associated 
with those who are not associate the procedure with a cutoff of 10.5 ng / ml, and those in 
which MI was directly associated with the placement of non-hemoductos with a cutoff of 
35.5 ng / ml. 
In peri-operative myocardial infarction not associated with coronary bypass grafts, is due to 
mechanisms such as inadequate cardioplegic perfusion, incomplete revascularization, distal 
coronary microembolization caused by surgical manipulation, recent unstable angina, poor 
left ventricular function. This early detection of perioperative myocardial infarction plays an 
important role in treating either early coronary angiography and angioplasty, trying to 
preserve left ventricular function as a predictor of long-term survival. Obviously the 
presence of perioperative myocardial infarction is associated with a high rate of heart failure 
and long-term mediately, as evidenced by Steuer, analyzing patients with MVR 7.493 
assessing the number of readmissions for heart failure. Found that 7.7% (576) were 
readmitted for heart failure. Of these, 20% (114) had perioperative myocardial infarction. 
76,77,78,79,80,81 
www.intechopen.com
 
Special Topics in Cardiac Surgery 26
Tamponade 
It is characterized by symptoms and signs of hemodynamic instability due to the restrictive 
effect on cardiac contraction, usually observed within the first 6hrs associated with poor 
permeability of their drains. The prevalence of this complication varies between different 
publications, ranging from 0.8% -8.5%, there are reports in which said one of the most 
frequent causes, to the use of internal mammary artery for coronary artery bypass bridge, on 
the other hand, the use of a single anterior mediastinal tube, instead of 2 tubes (front and 
back) has been associated with a high rate of pericardial fluid and as a result of these 
patients tamponade.La course evaluation should be carried out by echocardiography, and 
not just those with a radiological image suggestive of this entity (heart carafe), since by this 
method because of cardiac surgery postoperative patients identified only 50% of patients. 
This is important because several studies have shown that those patients who develop 
pericardial effusion, even without hemodynamic compromise, increased risk of 
supraventricular arrhythmias, sternal dehiscence, prolonged hospital stay and a significant 
reduction in exercise tolerance. 82,83,84 
Finally, the treatment will be those with hemodynamic compromise, is permeated drains, by 
performing emergency echocardiography and reoperation. 85,86,87,88,89 
Vasoplegic Syndrome 
Vasoplegic syndrome (SV) is a severe form of systemic inflammatory response syndrome 
(SIRS), which ranks its expression on the cardiovascular system. A number of reports 
considered the vasoplegia as a recognized complication of cardiac surgery, the main clinical 
manifestation is the presence of hypotension, usually severe, which features the distinctive 
clinical feature of responding with little or no input from volume. 
In cardiac surgery, the reported incidence is 8 to 10%, even up to 40%, these differences 
often depend on characteristics of the study population (ventricular function), the type of 
intervention assessed (use or not of CPB, type cardioplegia) and mainly from the diagnostic 
criteria used. As mentioned previously, the key point is the presence of hypotension, usually 
with a systolic blood pressure (SBP) <85 mm Hg, and / or mean arterial pressure (MAP) <50 
mm Hg.Un clinical data necessary to consider the diagnosis of Vasoplegia is the lack of 
response to volume expansion. A hypotensive patient in the postoperative period of cardiac 
surgery, central venous pressure (CVP) reduced elevation of the same after the infusion of 
500 or 1000 ml of solutions (even at higher volumes) should lead to the posing of vasoplegia. 
90,91,92,93 
Strict diagnostic confirmation will require the use of hemodynamic monitoring, the presence 
of Swan Ganz catheter will allow a broader determination descended filling pressures, by 
providing values of pulmonary capillary pressure (PCP) reduced. 
Diagnostic criteria 
1. Clinical (only allow them to suspicion) 
Low blood pressure response with little or no volume expansion aapropiada 
2. Hemodynamic 
Hypotension (SBP <85 mm Hg / TAM <50 mm Hg) 
Reduced filling pressures (CVP <5 mm Hg / Wedge <10 mm Hg) 
Minute volume and normal or elevated cardiac index (CI equal to or greater than 2.5 
L/min/m2) 
Reduced systemic vascular resistance (SVR <800 dinas/seg/cm-5) 
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Vasopressor requirement (> 0.5 mcg / kg / min noradrenaline or> 10 mcg / kg / min 
dopamine) 
3. Other 
a. In operating room, with open chest 
PVC hypotension with low (<5 mm Hg) refractory avolumen associated with 
excellent observation of left ventricular contractility. 
b. postoperative 
PVC hypotension with low (<5 mm Hg) refractory avolumen associated with 
echocardiography (bidimensionalcon good window or transesophageal) with 
apreciaciónde good left ventricular contractility. 
The main therapeutic goal is sustain perfusion to vital organs like the kidney, brain, liver 
and heart. This also implies the initial use of volume, the use of two types of drugs, drugs 
with pressor effect, linked to its exclusive or non-selective action on alpha adrenergic 
receptors, such as metaraminol or phenylephrine among the first, and epinephrine, 
norepinephrine or dopamine among the latter. The use of drugs associated with beta-
adrenergic effect, will result in some measure, an increase of myocardial oxygen 
consumption in the same direction, their association with postoperative arrhythmias, has 
also been reported. The second drawback associated with, and probably the most 
important clinical refractoriness to vasopressors is that certain forms of vasoplegia 
postoperative manifest. This refractoriness drugs raises the utility of antagonists or 
inhibitors of NO and the enzyme guanylate cyclase, we consider a rational therapeutic 
approach more physiological. Two drugs are the most studied, methylene blue, and 
vasopressin 94,95,96,97,98 
Methylene Blue (AM): its therapeutic action is based on the inhibitory effect of NO or 
blocking of the enzyme guanylate cyclase. This drug has been considered in several isolated 
reports in a series without a control group and essentially in a randomized control group. 
Leyh et al. reported 54 patients with refractory postoperative vasoplegia the use of 
norepinephrine, treated with 2 mg / kg AM. Fifty-one patients showed favorable 
hemodynamic changes in the course of one hour post-treatment. Three patients died in the 
hospital course of the picture (5.6%). The study lacked a control group. Another key finding 
is the shorter of the table between those treated with AM. In these, vasoplegia resolved 
completely within two hours after the start of infusion, whereas in those managed 
conventionally, the box is extended in time, such extension of time associating with a higher 
incidence of complications and late onset sepsis and multiorgan dysfunction . Several 
authors have agreed with this finding, giving unfavorable prognostic value of the 
persistence over time of the SV, accepting that a breakpoint located between 36 and 48 hours 
is a marker of poor prognosis. 
Vasopressin: Vasopressin (antidiuretic hormone arginine vasopressin), Argenziano et al. 
described the association between the shock with vasodilatation after bypass surgery and 
deficiency of vasopressin. Which is secreted by the neurohypophysis regulates tubular 
permeability to water, typically having limited participation in the control of BP. Under 
conditions of hypotension, such as bleeding or vasoplegia itself is a rapid depletion of 
endogenous. It allows a rapid reversal of hypotension, especially in patients refractory to 
vasopressors. In addition, the hormone increases vascular sensitivity to catecholamines and 
increases urine output, based on its direct action on glomerular efferent arteriole, unlike 
catecholamines, whose site is located on the therapeutic afferent arteriole. The proposed 
dose is 0.05 to 0.1 unit / minute. 
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The use of off-pump surgery was associated with less inflammatory response, with lower 
incidence of postoperative SV. However, the picture is commonly seen and may present a 
favorable course. Vasoplegic syndrome is associated with a poor prognosis, when it is 
resistant norepinerina poorer prognosis with increased morbidity and mortality. The 
reported mortality after cardiac surgery is 24% in series reported by Levin and colleagues, 
and 25% in series reported by Gómez et al, in which case the syndrome persisted for up to 
48hr vasoplegic. 99,100,101,102,103 
7. Drug therapy 
The support with vasopressor, vasodilator and inotropic therapeutic behavior is common in 
the first 24 hours secondary to hemodynamic effects induced hypothermia, myocardial 
stunning, extracorporeal circulation, hypovolemia, sedation, and so on. Despite the 
frequency of use of catecholamines are well known adverse effects such as increased 
myocardial consumption, arrhythmogenic, favor delirium, and so on. 104,105,106 
Dobutamine 
Amine as the structure similar to dopamine is primarily a beta-adrenergic agonist relatively 
selective beta-1. Is much more effective and positive inotropic and positive chronotropic 
capacity less arrhythmogenic than dopamine, has no affinity to dopamine receptors and 
therefore lacks the renal effect. A standard dose (2-15μg/kg/min) positive inotropic 
responses observed with a slight increase in heart rate and decreased peripheral resistance. 
107,108 
In the perioperative setting is used primarily as inotropic, often combined with vasopressor 
either to maintain adequate cardiac output and blood pressure and to achieve a combined 
effect of cardiac output and perfusion. On the other hand as shown by Susana Lobo et. al; 
randomizing 50 patients over 65 high-risk cardiac surgery, receiving IV fluids liquid + vs 
Dobutamine, the largest number of perioperative complications observed was present in 
those who do not use vs those who had dobutamine infusion: 52 % vs 16%, and mortality at 
60 days was 28% vs 8% in the dobutamine group. 109,110,111,112,113,114 
The drug's half life is 3-5 min, one of several effects is the progressive decrease in blood 
pressure and pulmonary wedge has an advantage over the effect of dopamine beta for a 
smaller effect observed tachycardic and arrhythmogenic action and dilation in the 
pulmonary circulation has been confirmed in the peripheral circulation. As observed 
Romson et al; administered dobutamine in varying doses and patients undergoing 
cardiopulmonary bypass the heart rate changes depending on the dose and this is lower in 
individuals over 65 years, there were minimal changes in blood pressure, instead a decrease 
in pulmonary capillary wedge pressure and central venous pressure increased systemic 
vascular resistance remained in a mild and constant left ventricular performance also 
increase due to increased heart rate 115,116 
Phosphodiesterase inhibitors 
They are a family of enzymes involved in cellular physiology by regulating the 
concentration of intracellular second messengers are known at present eight of these 
isoforms of phosphodiesterases, which interests us is the number III. Cyclic AMP, produced 
from the stimulation of beta-adrenergic receptors may have two destinations: the 
culminating with an increase in cardiac contractility, and the other consisting of the 
degradation of cAMP to 5-AMP, produced by phosphodiesterase III . Inhibition of this 
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enzyme protects cAMP, promoting their destination to the increase in contractility. It now 
has a group of inotropic drugs whose mechanism of action is precisely in the inhibition of 
phosphodiesterase-III. Of this group stand amrinone and milrinone for the extensive clinical 
experience has accumulated with its use. These substances belong to the bipyridines, this is 
a positive inotropic effect supplemented by a peripheral vasodilator, which contributes to a 
better ability to emptying of the heart. The hemodynamic effects of milrinone, administered 
as a loading dose of 50 micrograms / kg followed by continuous infusion of 0.35 to 0.75 
micrograms / kg / min is significant reductions in diastolic pressure in the aorta, the mean 
aortic pressure and systemic vascular resistance by about 11% ejection fraction of left 
ventricle is increased by about 14%, these effects are closely related to plasma 
concentrations. 117,118,119,120 
In the postoperative period especially in patients receiving milrinone pump has several 
effects on pulmonary circulation and inotropism as evidenced Mitsunori et al, which 
randomized 30 patients undergoing cardiac surgery treated with milrinone was reported, 
reduced the mean pressure of right atrial pressure in the pulmonary artery wedge, mean 
pulmonary pressure and systemic vascular resistance without making a significant change 
in mean arterial pressure or heart rate. 
On the other hand the use of Milrinone has been shown to be beneficial in patients 
undergoing CSRC bomb and right ventricular dysfunction prior. Jong H. et al analyzed the 
effect of infusion of milrinone in patients undergoing CSRC and right ventricular 
dysfunction (VD) found no increase in cardiac index, heart rate, and decreased systemic 
vascular resistance. Changes in right ventricular ejection fraction were not significant, 
whereas in cardiac output and RV afterload if they were, finally improves graft flow in the 
breast and in the middle cerebral artery during surgery of the CSRC. 
Dopamine 
Dopamine (D) precursor of norepinephrine in the biological synthesis, there are specific 
receptors for this substance, especially in the renal circulation, where it produces a 
vasodilatory effect which favors renal tubular function (Hiberman et.al 1984). At the heart 
there are dopamine receptors, but its function on contractility is weak and little known, this 
effect is not accompanied by an increase in resistance as pronounced as with peripheral 
epinephrine and norepinephrine under in vessels predominantly to dopamine receptor 
stimulation. 
The mechanism of action is dose dependent at relatively low doses (1-5μg/kg/min) 
stimulates dopamine receptors predominantly with subsequent renal and mesenteric 
vasodilation (Szerlip, et. Al 1991). A moderate dose of 5-10 mg / kg / min stimulates beta 
adrenergic receptors leading to positive inotropic effects and high-dose alpha-adrenergic 
stimulation 10-15μg/kg/min carries peripheral vasoconstriction. 
By perioperative is used for its effects on the renal circulation as well as its positive inotropic 
effect can be used in improving the ICC states inotropism significantly, the clinical effect is 
seen immediately as the drug's half life is 3 -4 min. Among its side effects can cause or 
exacerbate tachyarrhythmias, because its effect is mediated by increased levels of 
norepinephrine. At present medical evidence did not show benefit of using low doses of 
dopamine effect of splanchnic vasodilatation and renal function, however, this drug 
increases oxygen consumption at promoting tubular tubular ischemia, in addition there is 
poor correlation between blood levels with dose infused. 
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Norepinephrine 
Its structure is similar to that of epinerfrina is the endogenous neurotransmitter for 
postganglionic sympathetic nervous system, its basic function is to stimulate alpha-1 
receptors and less beta-1 receptors and beta-2. Intravenous administration of 
norepinephrine increases blood pressure by increasing peripheral vascular resistance due to 
this increase, heart rate tends to decrease due to a vagal reflex which overrides the 
stimulation of myocardial beta-1 receptors, their After stimulation of these receptors causes 
a recent positive inotropic effect especially at low doses. 
Under normal conditions this amine decreases renal blood flow (with minimal changes in 
glomerular filtration rate) and mesenteric, splanchnic and liver. The administration of 
norepinephrine should be through a central line to avoid tissue necrosis. Is much more 
convenient administration via infusion and the usual dose is 0.01 to 0.1 mg / kg / min or 2-
15 mcg / min. So perioperative norepinephrine may be used at low doses for its 
chronotropic effect and vasoconstrictive properties (intermediate dose). Especially for its 
effect on the peripheral circulation is indicated in cases where failure is demonstrated in the 
ability of vasoregulation, because it increases blood flow by increasing systemic blood 
pressure especially in shock. It should be used so cautious in patients with MAO inhibitors. 
The tx hypovolemic shock with norepinephrine leads to severe multiorgan hypoperfusion. 
The use of norepinephrine in patients undergoing cardiac surgery is controversial because 
of fear that has regard to the commitment in the function mediated renal vasoconstriction. 
Hiroshi Morimatsu, et. randomized 100 patients to post-operative heart to norepinephrine 
infusion in line and this study was carried out monitoring of renal function with infusion of 
norepinephrine in postsurgical hypotension TAM <70 mmHg. The results was an increase in 
central venous pressure, decreased systemic vascular resistance index with increased heart 
rate will eventually change in serum creatinine of treaties. Kwak Y, showed that one of the 
applications of norepinephrine after surgery is the treatment of hypotension in patients with 
chronic pulmonary hypertension as they are benefiting from the control of blood pressure 
without increasing the PSAP but rather decreases many of them. 
Nitroglycerin 
Its mechanism of action is through biotransformation in vascular smooth muscle by 
activating guanylyl cyclase thereby resulting in an increase of cyclic GMP and thus 
vasodilation. The effectiveness of nitroglycerin decreases after 18-24 hr by a phenomenon of 
tolerance due to decreased formation of nitric oxide in this way. The NTG has the ability to 
vasodilate both beds (arterial and venous) at low doses, dominated by its vasodilatory effect 
and increases venous capacitance and thus decreasing venous pressure and diastolic filling. 
However high doses of nitroglycerin significantly increases venous capacitance and 
systemic arteriolar resistance, thereby decreasing the systolic blood pressure and cardiac 
output. As a mechanism the body responds by reflex sympathetic tachycardia and 
peripheral arteriolar vasoconstriction, despite this effect on the coronary circulation is 
vasodilation of both healthy and affected artery atherosclerosis, and also increase collateral 
circulation areas although its main effect is on the arteries coronary larger caliber and low 
on resistance of lesser caliber. On myocardial oxygen requirements, mainly affects the 
ventricular wall tension by increasing venous capacitance, which in turn decreases venous 
return to the heart leading to a decrease in ventricular wall tension and myocardial oxygen 
consumption. Another beneficial effect is that the decrease in pre-produced increase in LV 
perfusion and favoring the subendocardium. 
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Their metabolism is primarily via hepatic glutathione by organic nitrate reductase. Its effect 
is dissipated in 30-60 min intravenous Its effect is achieved after 90 seconds and is dose 
dependent. The usual dose of 0.5-3 mg is / kg / min infusion or 5-200 g / min and 0.5 mg 
bolus. In post-qx therapy use in peri-and post-qx: 
- Myocardial ischemia associated with ventricular arrhythmias, especially when this is 
caused by halogenated anesthetics. 
- Myocardial ischemia with an increase in pulmonary capillary pressure associated with 
a persistence in the inhalation anesthetics. 
- Coronary Spasm 
- Intravenous administration has been proposed as prophylactic coronary bypass surgery 
to prevent episodes of ischemia by vasospasm 
- Useful for the treatment of hypertension during surgery RVM. 
Sodium nitroprusside 
One of the most commonly used vasodilators in the perioperative period, penetrating the 
endothelium acts to form nitric oxide, this results in the production of guanine 
monophosphate to guanine triphosphate. Thus cyclic GMP is the second messenger that 
triggers calcium binding. Its effect occurs seconds after the start of infusion. The commonly 
used dose is 1-40 mcg / min. 
At low doses predominantly dilated arteries and arterioles, and how the dose increases also 
becomes a venodilators. As with nitroglycerin may occur reflexively tachycardia. And 
increased venous capacitance and thereby reducing cardiac output. On the other hand it is 
important to consider that as an important arteriodilatador can produce the phenomenon of 
coronary steal, mostly because it does not vasodilation in arteries affected by atherosclerosis, 
reducing the flow in the latter. 
Among other effects has the ability to produce dilation of the pulmonary vascular bed 
arriving to produce hypoxia. Another effect is less desirable thiocyanate intoxication, which 
prevent tissue oxygen delivery by blocking the final stages of the respiratory chain. 
Its administration should be in glucose solution covering both the drug and the line 
connecting the infusion pump. The usual dose is 40 - 300 micrograms / min. Going to be 
titrated according to a patient's response. 
Vasopressin 
Vasopressin also known as antidiuretic hormone is a peptide product of the hypothalamus 
and stored in the posterior lobe of the pituitary. Feedback effects in several organs including 
the brain where it acts as a neurotransmitter regulating body temperature, nociception and 
adenocorticotropica hormone release. In the pulmonary vasculature, moderate dose of 
vasopressin causes vasodilatation while high doses produce vasoconstriction. Vasopressin 
also has other effects on thrombosis and hemostasis, including platelet aggregation and 
release of factor VIII and von Willebrand. 
Plasma levels of vasopressin in patients after undergoing bypass surgery ranges from 100 
-200 pg / ml, while the hemorrhagic shock promotes the release of plasma concentrations 
of 1000 pg / ml. Several publications indicate that the usual dose of this drug is between 
0.01 to 0.1 U / min, and is effective in patients with shock vasodilation without adverse 
effects. 
Hypotension refractory to high doses of alpha-adrenergic agonists after cardiac surgery, 
after the use of cardiopulmonary bypass, has been referred to as Sx vasoplegic. This 
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vasopressin has been used for this treatment with encouraging results. Masseti and 
colleagues studied 16 patients with intravenous vasopressin (0.1-1 IU / min) for the 
treatment of hypotension refractory to maximum dose of norepinephrine (> 30 mg / kg / 
min). Preoperative ejection fraction was 40.5% and NYHA functional class 3.5. Getting an 
increase in blood pressure of 89 mmHg baseline to 116, increase in SVR from 688 to 1043, 
decreased cardiac index from 2.6 to 2.9 L/min/m2, urine volume increased from 36.8 to 72.8 
ml / h. 
Whereas high doses of vasopressin and effective in the treatment of Sx vasoplegic after 
cardiac surgery with cardiopulmonary bypass. 
In a recent study, Argenziano et al found that about 10% of patients undergoing cardiac 
surgery experienced hypotension by vasodilation after bypass surgery, which not 
necessarily is associated with cardiogenic or septic shock. Interestingly, in situations in 
which hypotension persists after surgery RVM, smooth muscle cells become less sensitive to 
circulating catecholamines. This phenomenon is due to decreased function of adrenergic 
receptors, the study of 50 patients conducted at Columbia Presbyterian Medical Center 
undergoing cardiac surgery were treated with vasopressin in the operating room or 
intensive therapy in the first 24 hr surgery (6). All patients had less than 60 mmHg TAM and 
decreased systemic resistance, despite support with catecholamines. This administration of 
vasopressin infusion of 0.09 U / min increased the TAM from 58 to 75 mmHg, the SVR 
increased from 920 to 1200 dyne s cm and achieving a reduction in the administration of 
norepinephrine in 32%.  
Nesiritide 
Brain natriuretic peptide also known as BNP is a neurohormone secreted by the left 
ventricle in response to increased stress (both pressure and volume in the varga) in the 
ventricular wall. Physiological actions of BNP include natriuresis, vasodilation and 
neurohormonal modulation. So the tx with BNP has emerged as a viable option in the tx 
of acute CHF. Moreover, its determination of serum is currently used to differentiate 
cardiac dyspnea pulmonary dela type. In general, levels of BNP 100pg/ml excludes 
minors 1 decompensated CHF, whereas values greater than 500pg/ml indicates 
decompensation. 
Neseritide is the recombinant form of endogenous human BNP. Has been shown to 
decrease filling pressures, increase cardiac output and improve the clinical condition of 
patients with decompensated CHF. In August 2001 was approved by the FDA for tx of 
CHF in those with decompensated dyspnea at rest or with minimal effort. The 
recommended dose is 2μg/kg initial bolus followed by infusion of 0.01μg/kg/min 
extended to a maximum of 48 hr. 
Several studies have examined the possible application of perioperative neseritide so, in 
patients with left ventricular dysfunction who will undergo heart surgery. In a study 
prospectivco, open, randomized controlled, Brackbill et al examined the use of 
perioperative infusion of neriritide and showed improvement compared with milrinone. 
We included 40 hemodynamically stable patients with LVEF 35% or less that were 
undergoing bypass surgery. And they were randomized to a bolus of nesiritide or 
milrinone intraoperatively followed by an infusion of any of them for 24 hr. The time 
spent in post-qx therapy was the primary outcome measure. The incidence of post-qx ICC, 
the rate of readmission within 30 days, mortality and other clinical parameters were 
compared. Patients receiving nesiritide had a hospital stay of 50.6 + / - 46.8 hours 
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compared with 44.1 + / - 23.5 hours of receiving milrinone (p = 0.57). The incidence of 
post-qx ICC also showed no significant results in both groups (p = 0.25). On the third day 
of follow up, no significant differences in SBP readmission between the two drugs and 
there was no impact on mortality, the authors concluded that nesiritide does not reduce 
hospital stay post-qx like not modify other parameters of disease compared with 
nesiritide in MVR and stable ventricular function. 
In a prospective double-blind (NAPA) Mentzer et al; consider the role nesiritide might play 
in patients with left ventricular dysfunction with MVR with cardiopulmonary bypass. 
Patients with ejection fraction less than or equal to 40% who underwent MVR and DCP 
were randomized to receive nesiritide or placebo for 24-96 hr after induction of anesthesia. 
The post-qx renal function, hemodynamic parameters and drug use (primary endpoints) 
were evaluated in patients with MVR with DCP, mortality and safety (secondary endpoints) 
were evaluated in all patients who received the drug, 303 patients randomized, 279 received 
the drug and 272 underwent MVR with DCP. Compared with placebo, nesiritide was 
associated with a slight increase in serum creatinine (0.15 + / - 0.29 mg / dl versus. 0.34 + / - 
0.48 mg / dl, p <0.001) and a fall in glomerular filtration rate (- 10.8 + / - 19.3 mL/min/1.73 
m (2) versus -17.2 + / - 21.9 mL/min/1.73 m (2), P = 0.001) during hospital stay or stay on 
14. On the other hand, patients treated with nesiritide had a shorter hospital stay (p = 0.043) 
and lower mortality at 180 days. (P = 0.046). The authors concluded that nesiritide in the 
context of RVM with CPB is associated with improved renal function post-qx and possibly 
increased survival.  
8. Medical treatment 
Aspirin 
There are currently a total of 8 studies with more than 2500 patients using aspirin CSRC. The 
doses used 325-1200 mg daily. Two of these studies showed significant benefit of aspirin a 
day after heart surgery. In contrast to the other 6 that saw no difference vs placebo with 
regard to occlusion of the bridges managed belatedly. In conclusion, the evidence so far 
suggests that the use of aspirin to reduce occlusion of coronary artery bypass bridges to 12 
months after CSRC when given the 1st day after surgery, on the other hand is a medicine 
economic which is associated with few adverse effects and is of great benefit for patients 
with coronary artery disease peripheral with that aspirin should be given the most quickly 
as possible after cardiac surgery and continued indefinitely.  
HIipolipemiantes 
There are three studies involving 1900 patients to evaluate the use of these agents on the 
occlusion of coronary artery bypass grafts and the risk of cardiovascular events): The Post-
CABG trial, LOCATE (Lopid Coronary Angiography Trial) and Cholesterol Lowering 
Atherosclerotic Study ( CLAS). All three showed a significant reduction in the progression 
of atherosclerosis in coronary artery bypass bridges. Thus the long-term use of lipid-
lowering drugs prevent the progression of atherosclerosis in both native arteries and in 
coronary bridges and reduces cardiovascular events, it was shown that the use of these 
agents reduces the progression of atherosclerosis after 2 years RVM.  
Pan et al, found that after adjusting the demographic and clinical differences, the 
preoperative use of statins was associated with a 50% reduction in mortality, but showed 
no benefit in the occurrence of AF or IM. Dotan et al, found that statins were associated 
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with a significant decrease in cardiac mortality, unstable angina and arrhythmias 60 days 
to 1 year.  
Beta blocker 
Its use has been assessed by many studies, but in a perioperative cardiac surgery, Sjölander 
et.al, conducted a controlled double-blind study of 967 patients with MVR. Patients were 
randomized 4 to 21 days after RVM receiving 50 mg of metoprolol 2 times per day x 2 weeks 
and 100 mg of metoprolol per day vs placebo 2 x 2 years. There was no significant difference 
between the 2 study arms with respect to exercise capacity, however cn patients placebo had 
a higher rate of chest pain compared with the metoprolol group. On the other hand no 
significant difference in both groups with regard to revascularization, unstable angina, 
nonfatal MI or death at 2 years of follow-up.  
Finally, Ferguson et al, in a cohort study investigated the use of preoperative B-blocker in 
629 877 patients undergoing CSRC and showed a reduction to 30 days of drug-related 
mortality (OR 0.90, 95% CI0.87-0.93 ). This decrease was consistent with all groups of 
patients except those with LVEF <30% where there was no demonstrated benefit.  
Calcium antagonist 
Only one study has examined the effect of calcium antagonists initiated after surgery RVM, 
Gaudino et al; evaluating the benefits of calcium antagonists after the first year of 
revascularization. A total of 120 patients with normal perfusion function were randomized 
after 1 year of tx with 120 mg diatiazem to continue with or stop. No significant differences 
after 4 years of follow-up among the group of calcium antagonists and those who 
discontinued tx with respect to recurrence of angina (10% vs 12%), residual ischemia, 17% vs 
18%) and cardiac death 2% vs 0%). In short there is little evidence to support the routine use 
of calcium antagonists or nitrates after cardiac surgery.  
ACEI 
Despite the known benefits of ACE inhibitors, only 4 studies examined perioperative 
prophylactic use of ACE inhibitors in patients with MVR. QUO VADIS In the study 149 
patients were randomized to quinapril 40mg/día or placebo for 4 weeks before elective 
surgery RVM, treatment was continued for 1 year. The researchers found that quinapril 
significantly reduced 1-year clinical events, such as death from cardiovascular causes.  
9. Anticoagulants and antithrombotics management 
Thromboembolism and bleeding associated with anticoagulation comprise about 75% of the 
complications associated with prosthetic valves. antithrombotic therapy can reduce but not 
eliminate the possibility of this catrastofe. It is reported that the incidence of perioperative 
arterial thromboembolism is approximately 0.4 to 1.5% and the annual risk of stroke in high 
risk patients without anticoagulation is> 5.6% and <2.0% of major bleeding. 
The risk for thrombus formation with prosthetic heart valves is seven times higher in the 
first month after valve replacement during the following months, years intracardiac 
position independent. The underlying pathophysiology of activation are factors in the 
systems of intrinsic and extrinsic coagulation of synthetic surface extracorporeal 
circulation of blood or from contact with surfaces or tissue devoid of collagen, a 
significant number of surgeons in favor of delaying the anticoagulant because the risk of 
bleeding, the incidence of pericardial tamponade and reoperation is eight times higher in 
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patients treated with high doses of heparin than in those treated with low-dose heparin 
for prevention of venous thrombosis. 
Anticoagulation is recommended in the following cases: 
 Lifetime on all patients with mechanical valves 
 Lifetime in patients with biological valves who have other indications for 
anticoagulation Vgr: atrial fibrillation, heart failure, ventricular ejection fraction less 
than 30% left. 
 For the first three months in patients with bioprostheses after insertion, with a target 
INR of 2.5. No emabrgo strategy with aspirin (low dose-100 mg DE75) is an alternative, 
but there have been no randomized studies supporting the safety of this strategy. 
There is no consensus at the time of initiation of anticoagulation after surgery, but should 
begin during the first days postoperatively. (5 + -2) 
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